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Pelvic inflammatory disease (PID), a spectrum of inflammatory disorders of the 
female upper genital tract, is a serious complication of sexually transmitted infections (STIs) 
that may lead to chronic pelvic pain, ectopic pregnancy, and tubal infertility. Although PID 
treatment is critical for the preservation of fertility and health-related quality of life, many 
young women diagnosed with PID do not fully adhere to treatment recommendations. 
Interventions focused on clinician practices, patient education, and behavioral modeling have 
generated limited improvements in outpatient PID treatment adherence among young 
women, thereby suggesting the influence of other determinants, such as psychosocial factors. 
Coping and social support are psychosocial factors that may affect PID self-management. A 
comprehensive literature review revealed a dearth of published research focused on coping 
with PID and related social support among young women. Guided by the Transactional 
Model of Stress and Coping, this dissertation study used a convergent mixed methods design 
to examine and explore the coping strategies, social support, and self-management behaviors 
(medication completion, clinical follow-up visit attendance, partner notification, and sexual 
abstinence) of 90 young women during the PID treatment period. Study participants 
comprised a subsample of young women enrolled in a randomized controlled trial of an 
outpatient intervention designed to reduce adverse outcomes after PID. Quantitative data 
were collected via audio computer-assisted self-interview and structured in-person 
interviews. Qualitative data collection consisted of semi-structured interviews with 18 
participants to explore the experiences of young women diagnosed with and treated for PID. 
Quantitative results indicated that the social provision of opportunity for nurturance 




(AOR=1.26, 95% CI: 1.00-1.59, p=0.05) and clinical visit attendance (AOR=2.43, 95% CI: 
1.19-4.93, p=0.01). Qualitative findings revealed that upon learning about their diagnosis, 
young women were self-motivated to ameliorate PID. With support from family and friends, 
they incorporated PID self-management into their daily lives—which may not have been 
fully consistent with prescribed medical protocols. In conclusion, social support is associated 
with PID self-management among young women. Assessing young women’s coping and 
social support resources can inform a tailored plan for successful PID treatment. 
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CHAPTER ONE: INTRODUCTION 
Background 
Each year, approximately 800,000 cases of pelvic inflammatory disease (PID) are 
diagnosed in the United States (Greydanus & Dodich, 2015). Between 2006 and 2010, an 
estimated 2.6 million reproductive-aged women reported receipt of PID treatment in their 
lifetime (Leichliter, Chandra, & Aral, 2013). PID comprises a spectrum of inflammatory 
disorders of the female upper genital tract, including salpingitis, endometritis, tubo-ovarian 
abscess, and pelvic peritonitis (Centers for Disease Control and Prevention, 2015; 
Handsfield, 2011). Arising from an ascending genital infection unrelated to childbirth or 
invasive procedures of the genital tract, PID is a serious complication of sexually transmitted 
infections (STIs). At least 90% of primary episodes of PID are sexually acquired; few cases 
are attributed to non-sexually transmitted pathogens (Handsfield, 2011). Sexually transmitted 
organisms, such as Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT), are 
involved in many PID cases (Centers for Disease Control and Prevention, 2015; Handsfield, 
2011). CT is the most common cause of acute PID in industrialized countries, and probably 
the cause of most subclinical cases. GC is a major cause of PID in populations and 
geographic settings where gonorrhea is common (Handsfield, 2011).  
Although PID is an acute disease, poorly managed PID has significant chronic 
implications; women with PID may develop chronic pelvic pain, ectopic pregnancy, and 
tubal infertility (Brunham, Gottlieb, & Paavonen, 2015; Greydanus & Dodich, 2015). At least 
20% of PID cases occur in adolescents (Greydanus & Dodich, 2015), who are at increased 
risk for subsequent STIs and PID (A. M. Kelly, Ireland, & Aughey, 2004; Trent, Chung, 




by untreated STIs, STI treatment and prevention are critical for the preservation of fertility 
and health-related quality of life among young women diagnosed with PID (Brunham et al., 
2015; Greydanus & Dodich, 2015).  
PID Management 
The results of the Pelvic Inflammatory Disease Evaluation and Clinical Health 
(PEACH) study, a large, multisite randomized clinical trial and related cost-effectiveness 
analyses recently shifted treatment of mild to moderate PID from inpatient care to the 
outpatient setting (Smith, Cook, & Ness, 2007; Smith, Ness, & Roberts, 2007; Smith, Ness, 
Wiesenfeld, & Roberts, 2007; Smith, Tsevat, Ness, Wiesenfeld, & Roberts, 2008). The 
current standard of care for treatment of mild to moderate PID includes a 14-day course of 
outpatient oral antibiotic therapy and pain management, partner notification for treatment, 
sexual abstinence until patient and partner are treated, and a follow-up evaluation within 72 
hours (Centers for Disease Control and Prevention, 2015). Consistent condom use at the 
resumption of sexual intercourse reduces the risk for STI reinfection and new PID 
occurrences; after adjustment for covariates such as age, race, nonmonogamy at baseline, 
new partner at baseline, GC or CT at baseline, and use of other forms of contraception, the 
relative risk for recurrent PID among consistent condom users compared with nonusers was 
0.5 (95% CI: 0.3-0.9) (Ness et al., 2004). 
Although large randomized clinical trials such as the PEACH study have 
demonstrated that more expensive inpatient antibiotic treatment does not afford additional 
clinical efficacy compared to outpatient antibiotic treatment for mild to moderate PID (Ness 
et al., 2002), adherence to the Centers for Disease Control and Prevention (CDC)-




young adult women 13 to 25 years old) remains suboptimal (Trent, 2013b). The longitudinal 
outcomes of clinical trials suggest that outpatient PID treatment presents significant self-care 
or self-management challenges for young women. Within seven years of PEACH study 
enrollment, over 20% of women had recurrent PID. Many young women diagnosed with PID 
do not achieve full adherence to CDC treatment recommendations (A. M. Kelly et al., 2004; 
Trent et al., 2011). Medication adherence measured by electronic event monitoring in a 
subgroup of PEACH study participants demonstrated that women took an average of 70% of 
prescribed doses of doxycycline, took the prescribed two daily doses for less than 50% of 
outpatient treatment days, and took only 16.9% of doses within the optimal timing interval 
(Dunbar-Jacob, Sereika, Foley, Bass, & Ness, 2004). Approximately 29% of PEACH study 
participants reported that their partners received STI treatment after their PID diagnosis, and 
approximately 15% reported failure to abstain from sexual intercourse during the PID 
treatment period (Trent et al., 2011).  
A retrospective chart review of adolescents diagnosed with PID at an urban teen 
clinic revealed that 47% of those adolescents had at least one additional prior or subsequent 
episode of PID. Only 36% reported that their partners received STI treatment. Clinical 
documentation suggested that 23% of patients did not adhere to the medication regimen and 
sexual abstinence recommendations. Compared to girls with recurrent episodes of PID, girls 
with only one PID episode were 1.44 times more likely to report adherence to treatment 
recommendations. Girls with only one episode of PID were 2.47 times more likely than their 
counterparts with recurrent PID to always report that their partners had been treated. Sixty 
percent of girls with recurrent PID never reported that their partners received treatment, and 




have limitations dependent upon the accuracy and thoroughness of clinical documentation 
and patient self-report, study results suggest that adolescents with recurrent PID were less 
adherent to treatment and self-care recommendations than their single-episode peers (A. M. 
Kelly et al., 2004). 
Compared to their older counterparts, young women diagnosed with PID are at 
increased risk for subsequent STIs and PID, and adverse reproductive health outcomes (Trent 
et al., 2008; Trent et al., 2011; Trent, 2013b). At 30-day follow-up, 20% of adolescent 
PEACH study participants tested positive for an STI, compared to 5.2% of adult participants 
(Trent et al., 2011). In a separate study of adolescents who received outpatient treatment for 
PID, 34% were diagnosed with CT, GC, and/or PID during the 48-month follow-up period 
(Trent et al., 2008). Although the CDC identifies adolescents as a special population in the 
STD Treatment Guidelines (Centers for Disease Control and Prevention, 2015), there are no 
longer special considerations for PID treatment among adolescents. Analyses of PEACH trial 
data led to the conclusion that inpatient treatment for mild to moderate PID would not be 
cost-effective for patients of any age. However, the PEACH trial had low representation 
among patients in early and middle adolescence: The mean age of participants younger than 
19 years was 17.8 (SD = 1) years, which suggests that PEACH trial findings related to the 
effectiveness of outpatient treatment and self-management may not be applicable to younger 
adolescents (Trent, 2013a).  
A quality improvement intervention for the outpatient management of PID in 
adolescents increased the proportion of emergency department (ED) and clinic patients who 
returned for follow-up care within 72 hours from 10% to 43%. However, patient adherence to 




up for care, and almost 40% of patients had not completed taking their medications at two 
weeks post-diagnosis. In structured follow-up telephone interviews, 47% of patients did not 
identify what prevented them from following up for care, and 20% could not provide a 
reason for their failure to complete the prescribed medication regimen (Trent, Judy, Ellen, & 
Walker, 2006). In a randomized controlled trial of a brief video behavioral intervention for 
adolescents with mild to moderate PID, only 24% of all patients returned for a 72-hour 
follow-up clinical visit, and almost one-third of all participants did not complete their 
medications, with no statistically significant differences between the intervention and control 
groups (Trent, Chung, Burke, Walker, & Ellen, 2010). Clinical quality improvement and 
behavioral interventions have generated limited improvements in outpatient PID treatment 
adherence, which suggests that factors beyond clinician practices, patient education, and 
behavioral modeling influence PID self-care. Psychosocial factors, such as coping strategies 
and social support, may influence self-care behaviors among young women diagnosed with 
PID, and therefore warrant exploration.  
Coping and Social Support 
The illness experience, receiving an illness diagnosis, and receiving medical 
treatment all may provoke reactions of stress in individuals. The ways that individuals 
experience and cope with stress influence whether and how they seek health care and social 
support, as well as their adherence to health care professionals’ recommendations (Glanz, 
Rimer, & Viswanath, 2008). Reactions to stressors can promote or inhibit positive health 
behaviors and influence motivation to practice health-promoting behaviors. A better 




effective strategies and programs for individuals to improve coping and enhance well-being 
(Glanz et al., 2008).  
Coping is defined as cognitive and behavioral efforts to manage specific external 
and/or internal demands that are appraised as taxing or exceeding the resources of the person 
(i.e., coping is the effort to manage psychological stress) (Glanz et al., 2008). Multiple 
approaches have been used to classify coping, including an emphasis on the focus of coping 
(i.e., a person’s orientation and activity in response to a stressor) or an emphasis on the 
method of coping (i.e., cognitive or behavioral efforts). Regarding the focus of coping, a 
person may approach the problem and make active efforts to resolve it (problem-focused 
coping) or try to avoid the problem and focus on managing the emotions associated with it 
(emotion-focused coping) (Zeidner & Endler, 1996). In general, problem-focused forms of 
coping are more likely when persons appraise conditions as amenable to change. Emotion-
focused forms of coping are more likely to occur in response to an appraisal that nothing can 
be done to modify harmful, threatening, or challenging environmental conditions (Lazarus & 
Folkman, 1984). Adequate coping allows for the achievement of goals (Perrez & Reicherts, 
1992). Because coping is a process connected to context, the appropriateness or adequacy of 
a coping strategy is determined by its effects in a given situation and in the long term; no 
coping strategy is inherently maladaptive or adaptive (Lazarus & Folkman, 1984; Zeidner & 
Endler, 1996). Central to the analysis of coping with stressors is the concept that a given 
event or situation is perceived in diverse ways by different people. Furthermore, these 
subjective perceptions, rather than the objective stressors, are the main determinants of 
effects on behaviors (Glanz et al., 2008). Subjective self-report is the primary source of 




 Social support is a resource for coping efforts, and may exist in the following forms: 
emotional, tangible, and informational (Lazarus & Folkman, 1984). Social support may be 
conceptualized as (1) perceived social support, (2) supportive relationships, (3) supportive 
networks, and (4) received social support. Perceived social support refers to the general 
belief that others are available and desire to help if the individual needs aid. Supportive 
relationships are dyadic social bonds from which persons can obtain resources that may 
facilitate coping. Supportive networks are groups of supportive relationships. Received 
support is the help that an individual obtains from others during a challenging situation. 
These conceptualizations of social support are not mutually exclusive, and no single 
conceptualization is sufficient to lead to a satisfactory understanding of the role of social 
support in coping (Zeidner & Endler, 1996). 
Background Literature 
A preliminary analysis from Technology Enhanced Community Health Nursing 
(TECH-N), a randomized controlled trial (RCT) of an intervention designed to improve 
health outcomes among young women with PID, indicated that 65% of young women with 
PID notified a parent of their diagnosis, and 74% of the young women who notified their 
parents received support such as advice, comfort, and medication reminders. Young women 
who reported a greater sense of responsibility for the well-being of others were less likely to 
notify a parent of their PID diagnosis. Young women who reported a greater sense that they 
could rely on others, or a greater sense that others recognized their competence and personal 
qualities were more likely to notify a parent of their PID diagnosis (Munoz Buchanan et al., 




examined. Increased understanding of PID self-care processes contextualized by coping and 
social support will allow clinicians to refine interventions to improve PID self-care. 
Although there is a paucity of research on coping strategies and social support 
associated with PID, there have been some investigations of coping strategies and social 
support within the context of self-care for other STIs and HIV. Young women use multiple 
coping strategies in response to an STI diagnosis. A cohort of 177 adolescent females with a 
history of at least one STI episode used a mean of 7.5 strategies to cope with their most 
recent STI diagnosis, with no differences by age or number of previous STI episodes. 
Wishful thinking (95%), problem solving (81%), and emotional regulation (79%) were the 
most frequently used coping strategies (Rosenthal, Biro, Cohen, Succop, & Stanberry, 1995). 
An extension of that research on adolescent females’ coping strategies in response to STI 
acquisition suggested that there are some differences in coping strategies used for an STI 
acquisition and coping strategies used for other interpersonal life stressors (e.g., stressor 
associated with a friendship). Problem solving was used less often in response to STI 
acquisition, and self-blame was used more often in response to STI acquisition (Baker et al., 
2001). Among 259 men and women between the ages of 18 and 56 years who received a 
diagnosis of GC or CT at STI treatment centers, problem-focused coping was significantly 
associated with consistent condom use one month after STI diagnosis. Persons who reported 
sexual activity with one-time partners or had more than one regular partner were more likely 
to use denial as a coping strategy. Partner notification was not associated with any of the 
coping strategies assessed one month after STI diagnosis (Schwartz et al., 2008). 
HIV-related research suggests that relationships between coping strategies and 




spiritual coping, professional help, and physical diversions moderate the relationship between 
stigma and antiretroviral medication adherence among adolescent and young adult females 
living with HIV. At low usage of these coping responses, stigma was negatively associated 
with medication adherence. With high usage of these coping responses, stigma was no longer 
associated with medication adherence (Martinez et al., 2012). 
Social support has been positively associated with HIV medication adherence 
(Edwards, 2006; J. D. Kelly, Hartman, Graham, Kallen, & Giordano, 2014; Scheurer, 
Choudhry, Swanton, Matlin, & Shrank, 2012), medical appointment attendance by people 
living with HIV (Bodenlos et al., 2007), STI-related care seeking (Fortenberry & Zimet, 
1999), and protective sexual behaviors, such as consistent condom use and secondary 
abstinence (Crosby et al., 2001; Crosby, DiClemente, Wingood, & Harrington, 2002; 
Mazzaferro et al., 2006). Women living with HIV revealed in qualitative interviews that 
emotional and instrumental forms of social support from family members helped them adhere 
to their HIV medication regimens (Edwards, 2006). High social support predicted high 
antiretroviral therapy (ART) medication adherence among persons 18 years of age and older 
with a new diagnosis of HIV. Baseline tangible support scores were higher in persons who 
subsequently had at least 95% adherence to ART. In multivariate logistic regression, high 
overall social support (adjusted odds ratio [AOR] = 2.36, p = 0.05) and high tangible social 
support (AOR 3.01, p = 0.02) predicted ART adherence equal to or greater than 95%. (J. D. 
Kelly et al., 2014). A systematic review to evaluate the association between social support 
and medication adherence indicated that social support was positively associated with 
medication adherence and fewer missed doses among persons with HIV (Scheurer et al., 




health care appointment attendance among persons with HIV (Bodenlos et al., 2007). 
Evidence suggests that most adolescents who seek STI-related care receive social support 
from parents and other family members, commonly in the form of informational support and 
companionship. The process of STI-related care-seeking often involves an adolescent’s 
social network, which provides a variety of coping resources that may make care-seeking 
easier (Fortenberry & Zimet, 1999). 
Compared to young women with high perceived social support, young women with 
low perceived social support were less likely to report consistent condom use (AOR = 0.28; 
95% CI: 0.14-0.57). Young women with low perceived social support were more likely to 
have a history of STI (AOR = 2.05; 95% CI: 1.13-3.71) (Mazzaferro et al., 2006). A 
supportive family may provide an environment that protects female adolescents from 
engaging in STI risk behaviors such as not using condoms. Adolescent females who did not 
reside in a supportive family were approximately twice as likely to report not using a condom 
during their most recent episode of penile-vaginal sex with a steady partner. Adolescents not 
residing in a supportive family were 2.8 times more likely to report that they had not used 
condoms for penile-vaginal sex in the past 30 days. Female adolescents who did not reside in 
a supportive family were approximately twice as likely to report fear of condom negotiation, 
low self-efficacy for condom negotiation, and high perceived partner-related barriers to 
engaging in safer sex (Crosby et al., 2002). Living with the mother in a supportive family 
may provide an environment that promotes protective sexual behaviors for sexually active 
female adolescents. After controlling for parental monitoring, parent-adolescent 
communication about sexuality, and age, adolescents residing with their mothers in a 




sex with any partner in the past 30 days, and approximately 50% less likely to report having 
sex with a non-steady partner in the past 6 months (Crosby et al., 2001). 
Significance of the Study 
 PID during adolescence and young adulthood increases vulnerability to long-term 
adverse reproductive health outcomes and negative health-related quality of life, including 
the challenges of chronic pelvic pain and infertility (Brunham et al., 2015; Greydanus & 
Dodich, 2015). The national focus on infertility prevention is indicated by the Healthy People 
2020 objective to reduce the proportion of reproductive aged women with impaired fertility 
(U.S. Department of Health and Human Services, 2018). The current study investigated 
factors associated with adherence to PID treatment recommendations among adolescents and 
young adult women and explored the context of PID self-care behavior. Previous studies of 
PID self-care behaviors have been limited to correlations with demographic characteristics 
such as age. Furthermore, prior research has not investigated the psychosocial barriers to and 
facilitators of PID self-care, nor explored the context of PID self-care behaviors. Because 
individuals’ subjective interpretations of health threats significantly influence their emotional 
and health behavior responses (Glanz et al., 2008), it is important to assess young women’s 
appraisals of PID. In this study, quantitative and qualitative data were collected and analyzed 
to identify factors that promote or hinder PID self-care among young women and to discover 
opportunities to improve adherence to PID treatment recommendations. In-depth interviews 
with adolescents and young adult women diagnosed with and treated for PID elucidated their 
appraisals of the diagnosis and their subsequent self-care processes. Results from surveys of 
attitudes, beliefs, and behaviors were merged with findings from in-depth interviews to 




PID has reported on the experiences of women 18 years of age and older, this study adds to 
existing knowledge by exploring the experiences of adolescents as young as 14 years old.  
Study Purpose  
The purpose of this dissertation study was to investigate the coping strategies, social 
support, and self-care behaviors of young women recently diagnosed with PID. Utilizing a 
convergent mixed methods design approach, this study examined and explored the 
psychosocial factors that influence adherence to PID self-management recommendations 
among young women. Enhanced understanding of the context of health behaviors by young 
women diagnosed with and treated for PID may inform clinical interventions that promote 
wellness and prevent future STIs and PID.  
Specific Aims and Associated Hypotheses 
A combination of quantitative and qualitative research methods examined barriers to 
and facilitators of PID self-care, while providing detailed, contextual information to achieve 
the following specific aims:  
Aim 1: To determine the coping strategies and types of social support utilized by young 
women diagnosed with PID.  
Aim 2: To examine the relationships among coping strategies, social support, and 
engagement in PID self-care behaviors among young women. 
Hypothesis 2.1: Young women who report greater use of problem-focused coping 
strategies (e.g., active coping, planning) will be more likely to engage in PID self-
care behaviors. 
Hypothesis 2.2: Young women who report higher levels of social support will be 




Hypothesis 2.3: Social support will moderate the relationship between coping 
strategies and engagement in PID self-care behaviors. 
Aim 3: To explore the experiences of young women diagnosed with PID. 
Conceptual Framework 
The Transactional Model of Stress and Coping (TMSC), a framework for evaluating 
processes of coping with stressful events, was used to develop the aims of this study. 
Developed by Lazarus and Cohen, the TMSC posits that stressful experiences are construed 
as person-environment transactions, in which the impact of an external stressor or demand is 
mediated by the person’s appraisal of the stressor (primary appraisal) and the psychological, 
social, and cultural resources at the person’s disposal (secondary appraisal). Coping 
strategies that are employed to achieve problem management and emotional regulation 
generate outcomes of the coping process (e.g., psychological well-being, health behaviors 
such as treatment adherence). Primary appraisal is an individual’s belief about the 
significance of an event as positive, challenging, irrelevant, benign, controllable, or stressful. 
Individuals initially tend to evaluate health problems as threatening or as negative stressors. 
Perceptions of susceptibility to the threat and perceptions of severity of the threat are two 
basic primary appraisals. Secondary appraisals include the perceived ability to change the 
situation, perceived ability to manage one’s emotional reactions to the threat, and 
expectations about the effectiveness of one’s coping resources. Coping strategies mediate the 
emotional and functional effects of primary and secondary appraisals. Coping outcomes are a 
person’s adaptation to a stressor, after appraising the situation and resources and being 




The TMSC was selected for the current study because it is an interpersonal model of 
health behavior. Self-management of PID is an interpersonal process, as it requires the 
adoption of protective sexual behaviors to prevent STI reinfection and may involve other 
persons for care and support. The PID self-management behaviors of interest include clinical 
follow-up visit attendance, medication adherence, partner notification, and sexual abstinence 
during the treatment period, all collected via self-report. The Brief COPE instrument was 
used to measure coping, the Social Provisions Scale instrument was used to measure 
perceived social support, and questions regarding the supportive care provided by 
parents/guardians were used to measure received social support. The TMSC adapted for the 
current study is shown in Figure 1.1. The quantitative research methodology of the current 
study examined coping strategies in response to PID and the influence of social support on 
PID self-care, while the qualitative research methodology used in-depth interviews to explore 
the processes of PID self-care after primary and secondary appraisals of PID. 
Dissertation Organization 
 This dissertation consists of six chapters. Chapter One provides an overview of the 
study, with attention to the purpose and aims of the dissertation, review of relevant 
background literature, the significance of the study, and the conceptual framework which 
guided the study.  
Chapter Two (Manuscript One) provides a comprehensive review of the published 
literature on coping strategies and social support experienced by adolescents and young 





Chapter Three describes the methodology used to conduct this research, including the 
study design, description of the parent study, study setting and sample, data collection 
procedures, data analysis plan, and protection of human subjects. 
Chapter Four (Manuscript Two) identifies social support and coping strategies 
utilized by 90 young women during the PID treatment period and examines their associations 
with the PID self-management behaviors of medication adherence, clinical follow-up visit 
attendance, partner notification, and sexual abstinence. This manuscript will be submitted to 
the Journal of Pediatric & Adolescent Gynecology for review. Included as an addendum to 
Chapter Four are tables that present the internal consistency reliabilities of the study 
instruments, the Social Provisions Scale and the Brief COPE. 
Chapter Five (Manuscript Three) reports major findings from the quantitative and 
qualitative exploration of coping with PID self-management among 18 young women 
diagnosed with mild to moderate PID. Descriptive statistics were used to analyze perceived 
social support, coping strategies, social support received from parents/guardians, and PID 
self-management behaviors. Semi-structured interviews were conducted to explore the 
experiences of young women diagnosed with and treated for PID. This manuscript will be 
submitted to Research in Nursing and Health for review. Included as an addendum to 
Chapter Five is the abstract for a qualitative exploration of PID diagnosis disclosure among 
young women, which was presented as a poster at the 2018 Annual Meeting of the Society 
for Adolescent Health and Medicine. The abstract was published in 2018, and the citation is 
as follows: Tillman, J. L., Robinson, K., Sharps, P, Wenzel, J., Alexander, K., & Trent, M. 
(2018). “My body, my business” – Diagnosis disclosure in the context of pelvic 




Chapter Six presents a concise summary of the dissertation and integration of 
findings. It concludes with a discussion of the contributions of this research to young 
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Psychosocial factors such as coping and social support may influence the health 
behaviors of adolescents and young adult women with pelvic inflammatory disease. The 
purpose of this review was to examine published research on coping strategies and social 
support experienced by adolescents and young adults diagnosed with pelvic inflammatory 
disease.  PubMed, PsycINFO, Web of Science, Embase, and CINAHL were searched for 
English language articles published through February 2017, using search terms including 
“pelvic inflammatory disease,” “coping,” “social support,” “Pelvic Inflammatory 
Disease/psychology," and “Adaptation/Psychological.” Manual searches of article reference 
lists and database searches for publications that cited previously identified articles were 
conducted to identify additional relevant articles. The search identified 54 articles, and two 
articles met the inclusion criteria. Acceptance was identified as a coping response to pelvic 
inflammatory disease in one study, and a second study indicated that perceived social support 
is associated with voluntary parental notification of the diagnosis and parental engagement in 
care. Research designed to identify effective coping strategies and social support in diverse 
populations and settings is needed to inform the development of successful interventions that 
preserve reproductive health and improve health-related quality of life of adolescents and 
young adults diagnosed with pelvic inflammatory disease. 
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Pelvic inflammatory disease (PID) comprises a spectrum of inflammatory disorders 
of the female upper genital tract, including salpingitis, endometritis, tubo-ovarian abscess, 
and pelvic peritonitis (Centers for Disease Control and Prevention, 2015b; Handsfield, 2011). 
An estimated 600,000 to 1 million PID cases are diagnosed in the United States each year 
(Handsfield, 2011). Arising from an ascending genital infection unrelated to childbirth or 
invasive procedures of the genital tract, PID is the most common complication of sexually 
transmitted infections (STIs) (Handsfield, 2011). At least 90% of primary episodes of PID 
are sexually acquired and attributed to sexually transmitted organisms, such as Neisseria 
gonorrhoeae (GC) and Chlamydia trachomatis (CT) (Centers for Disease Control and 
Prevention, 2015b; Handsfield, 2011).  
Estimates derived from Centers for Disease Control and Prevention (CDC) reports 
suggest that at least 20% of PID cases in the United States occur in adolescents (≤ 19 years 
old) (Greydanus & Dodich, 2015). Adolescents have a greater risk for subsequent STIs and 
PID, and adverse reproductive health outcomes than older women (Kelly, Ireland, & Aughey, 
2004; Trent, Chung, Forrest, & Ellen, 2008; Trent, Haggerty et al., 2011; Trent, 2013). PID 
poses a long-term threat to reproductive health, with complications that include chronic 
pelvic pain, ectopic pregnancy, and tubal infertility (Brunham, Gottlieb, & Paavonen, 2015; 
Greydanus & Dodich, 2015; Westrom, 1975). The most recent estimate indicates that total 
direct medical costs for PID and PID sequelae in the United States reach $1.88 billion per 
year (Rein, Kassler, Irwin, & Rabiee, 2000). Health economics studies have demonstrated 
that adolescents and adult women in the general population (i.e., with or without a history of 




outpatient or inpatient PID treatment (Smith, Tsevat, Ness, Wiesenfeld, & Roberts, 2008; 
Trent, Lehmann et al., 2011). Effective treatment and prevention of recurrences are critical 
for the preservation of fertility and health-related quality of life among adolescent and young 
adult (AYA) women diagnosed with PID.  
PID symptoms include lower abdominal pain, abnormal vaginal discharge, 
dyspareunia, and non-menstrual vaginal bleeding, although research suggests that subclinical 
or asymptomatic PID cases are common (Wiesenfeld et al., 2002). Severe PID cases include 
complicating symptoms, such as nausea and vomiting, which require hospital admission for 
treatment (Handsfield, 2011). The current Centers for Disease Control and Prevention (CDC) 
standard of care treatment guidelines for mild to moderate PID in non-pregnant women 
includes a 14-day course of outpatient oral antibiotic therapy and pain management, partner 
notification for treatment, sexual abstinence until patient and partner are treated, and a 
follow-up clinical evaluation by a medical or nursing professional within 72 hours of 
diagnosis and initiation of therapy (Centers for Disease Control and Prevention, 2015b). 
Although PID in pregnancy is rare, pregnant women diagnosed with PID should be 
hospitalized and treated with intravenous antibiotics due to their risk for complications such 
as preterm delivery (Centers for Disease Control and Prevention, 2015b). The current PID 
treatment guidelines from the CDC were influenced by the results of the PID Evaluation and 
Clinical Health (PEACH) study, a large, multisite randomized clinical trial to compare the 
effectiveness of inpatient and outpatient therapies. While the study confirmed prior reports of 
adverse outcomes in both treatment groups, there were no significant differences observed in 




treatment versus outpatient self-management of antibiotic therapy (Ness et al., 2002; Ness et 
al., 2005).  
Many AYA diagnosed with PID fail to fully adhere to the CDC-recommended 
treatment for PID (Dunbar-Jacob, Sereika, Foley, Bass, & Ness, 2004; Kelly et al., 2004; 
Trent et al., 2008; Trent et al., 2011). For example, in a subsample of PEACH study 
participants, medication adherence measured by electronic event monitoring demonstrated 
that participants took an average of 70% of prescribed doses of doxycycline and took the 
prescribed two daily doses for less than 50% of outpatient treatment days (Dunbar-Jacob et 
al., 2004). Failure to complete the antibiotic treatment regimen for PID increases 
susceptibility to persistent infection and ongoing inflammation, which may lead to PID 
sequelae (Rosenberg & Waugh, 1995).  
Multiple intervention strategies have been tested to improve adherence to PID 
treatment recommendations. A quality improvement intervention for the outpatient 
management of PID in AYA increased the proportion of emergency department (ED) and 
clinic patients who returned for follow-up care within 72 hours from 10% to 43%. However, 
the intervention was not successful in improving patient adherence. Fifty-seven percent of 
patients did not follow up for the recommended 72-hour follow-up care, and almost 40% of 
patients did not complete the course of prescribed medications (Trent, Judy, Ellen, & Walker, 
2006). In a randomized controlled trial of a brief educational video designed to improve PID 
self-management among adolescents diagnosed with mild to moderate PID, the odds of 
returning for a 72-hour follow-up medical visit were 2.65 times higher among adolescents 
who were randomized to the video intervention (Trent, Chung, Burke, Walker, & Ellen, 




hour follow-up visit was only 32%, and almost one-third of participants in the intervention 
and control groups did not complete their medications (Trent et al., 2010). The limited 
improvements in outpatient treatment adherence generated by clinical quality improvement 
and behavioral interventions suggest that factors beyond clinician practices and patient 
education influence PID self-care among AYA. Psychosocial factors such as personal coping 
strategies and social support may significantly influence self-care behaviors among AYA 
diagnosed with PID.  
The illness experience, receiving an illness diagnosis, receiving medical treatment, 
and medical self-management all may provoke reactions of stress in individuals (Glanz, 
Rimer, & Viswanath, 2008). The ways that individuals experience and cope with stress may 
influence whether and how they seek health care and social support, as well as their 
adherence to health care professionals’ recommended treatment protocols and follow-up 
visits. Reactions to stressors can promote or inhibit health behaviors and influence 
motivation to practice health-promoting behaviors (Glanz et al., 2008). Coping, defined as 
cognitive and behavioral efforts to manage specific external and/or internal demands 
appraised as taxing or exceeding the resources of the person, is the attempt to manage 
psychological stress (Glanz et al., 2008). Social support, or help obtained from others, is a 
resource for coping and commonly indicated as an important strategy on many coping 
instruments (Carver, Scheier, & Weintraub, 1989; Carver, 1997; Glanz et al., 2008; Spirito, 
Stark, & Williams, 1988).  
During adolescence and emerging adulthood, individuals move toward independence 
and autonomy, and the composition and dynamics of their social networks change. The peer 




adulthood. However, the family remains a critical source of support (Muuss, Velder, & 
Porton, 1996). AYA receive social support and other coping resources from parents, peers, 
and other social network members, and social support has been positively associated with 
well-being (Chu, Saucier, & Hafner, 2010). Physicians and nurses are a critical part of the 
support safety net for AYA who manage their own health care without the benefit of a 
personal social network. For interdisciplinary health care providers to develop and implement 
effective strategies to improve AYA health outcomes after PID, it is important to understand 
how AYA cope with a PID diagnosis and the role of social support in PID self-care outside 
the hospital setting. The objective of this paper is to examine the status of research focused 
on coping strategies and social support among AYA with PID.  
Methods 
Data Sources 
A comprehensive review of the literature was conducted to identify studies related to 
coping and/or social support among adolescents and young women diagnosed with PID. The 
literature review comprised peer-reviewed journal articles published in the English language. 
Five electronic databases—PubMed, PsycINFO, Web of Science, Embase, and CINAHL—
were searched for all articles published through February 2017.  To maximize the retrieval of 
relevant articles, we did not apply publication date limits to our search. Search terms 
included “coping,” “social support,” “pelvic inflammatory disease,” and specific PID 
disorders such as “endometritis” and “salpingitis.” In databases that used Medical Subject 
Headings (MeSH) terms, literature searches included MeSH terms such as “Pelvic 
Inflammatory Disease/psychology" and “Adaptation/Psychological.” Manual searches of 




identified articles also were conducted to identify additional relevant articles and ensure a 
sufficiently exhaustive search. 
Study Selection 
Articles were included for review if they presented original research on coping 
strategies by AYA in response to the stressors of receiving a PID diagnosis and PID 
treatment, or social support related to receiving a PID diagnosis and PID treatment. For this 
review, AYA is defined as the age range of 15 to 24 years, consistent with the “adolescents 
and young adults” population identified by the CDC (Centers for Disease Control and 
Prevention, 2015a). Articles were excluded from review if the study sample included AYA 
without a clear history of PID, and/or the results were not stratified by diagnosis to permit 
separate analysis of AYA who had been diagnosed with PID. Rigid quality assessment 
criteria were not used to further exclude studies, due to the paucity of studies focused on 
coping or social support identified in the literature. A single reviewer performed the literature 
search and compiled search results according to selection criteria, and two additional 
reviewers assessed the identified articles for inclusion in the manuscript.  
Analysis 
 For each included study, data were extracted on study type, setting and population, 
number of participants, study aims, the methods and instrument(s) used, and the results 
reported. Given the varied nature of the studies included in this paper, the data could not be 
combined in a meta-analysis. The studies are reviewed individually, and their applicability to 






The search for published literature yielded 84 initial results, published between 1978 
and 2016. Search results were imported into the Refworks reference manager program and 
checked for duplicates. Fifty-four papers remained after duplicates were removed. Each title 
was screened for inclusion/exclusion criteria, and potentially relevant papers were further 
assessed by abstract review. Forty-three papers were excluded after title/abstract screening 
based upon the following criteria: If the title and abstract had nothing to do with PID, then 
the study was excluded as off-topic. If the title and abstract did not pertain to social support 
or coping strategies after PID diagnosis, then the study was excluded. Of the eleven 
remaining results, nine did not meet the inclusion criteria for the following reasons: (1) lack 
of description of coping or social support after a PID diagnosis (n = 5); (2) editorial or 
opinion paper lacking original research (n = 2); or (3) inclusion of study participants with and 
without a history PID, without results stratified by PID history and AYA age (n = 2). Two 
full-text articles met the inclusion criteria for this review. A PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) flow diagram in Figure 2.1 shows the 
steps taken and the number of references included and excluded at each stage (Moher, 
Liberati, Tetzlaff, Altman, & PRISMA Group, 2009). 
Coping with PID 
Our search yielded no studies with a specific objective to examine coping with a PID 
diagnosis among AYA, or women of any age.  However, a cursory recount of coping 
occurred in one qualitative study that investigated women’s health care experiences and the 
impact of the PID diagnosis on their feelings about their health. Newton et al. (2014) 




Melbourne, Australia who were diagnosed with PID at a metropolitan sexual health clinic, 
metropolitan public hospital, or general practice office. The effect of the PID diagnosis on 
the women’s feelings about their health was one theme derived from the interviews. Some 
women conveyed that finding out about their PID diagnosis increased their body awareness 
and made them more likely to pay attention to symptoms in the future. However, there was 
no specific discussion regarding how the women managed their diagnosis and adhered to 
treatment recommendations (i.e., took care of themselves to cure PID and prevent future 
recurrences). A few women (n = 8) expressed the shock of discovering something was wrong 
with their normally healthy body and discussed how the PID diagnosis generated anxiety 
about their overall health. One coping strategy described by the participants was acceptance, 
which reflected their attempts to adjust to a perceived future of infertility. Most women in the 
study had been diagnosed with PID relatively recently (i.e., less than four months prior to 
study participation), thereby reducing the risk for recall loss as they recounted their 
experiences. 
Social Support for AYA with PID 
 Social support within the context of a PID diagnosis was studied in a sample of 187 
young women 14-25 years old (mean 18.4 years [SD = 2.2]) participating in a randomized 
control trial designed to evaluate a community health nursing intervention supplemented by 
text message communication to reduce short-term adverse health outcomes among young 
women diagnosed with PID (Munoz Buchanan et al., 2016).  The purpose of the study was to 
examine factors associated with parental notification initiated by young women diagnosed 
with PID and subsequent parental involvement in the young women’s PID care. Parental 




parent or legal guardian about your PID diagnosis?”—was the primary outcome of the study. 
Perceived social support (i.e., the belief that others are available and desire to help if the 
individual needs it) was operationalized as the Social Provisions Scale (SPS), a 24-item 
instrument that measures social support in six domains: attachment (emotional closeness that 
provides a sense of security), social integration (a sense of belonging to a group with similar 
interests and concerns), reassurance of worth (acknowledgment of one’s competence, skills, 
and value), reliable alliance (assurance that others can be counted on for tangible aid), 
guidance (advice and information), and opportunity for nurturance (the sense that others 
depend upon oneself for their well-being) (Cutrona & Russell, 1987). The SPS includes four 
items for each of the six domains, which are scored on a four-point scale (1 = “strongly 
disagree” to 4 = “strongly agree”). Higher scores indicate a greater level of perceived social 
support. Received social support (i.e., help obtained from others) examined in this study was 
parental engagement in PID care, which included the provision of medication reminders, 
advice, or comfort. Parental engagement in PID with care was reported in aggregate, and not 
itemized by specific support activity.  
Among the AYA diagnosed with PID in the Munõz Buchanan et al. (2016) study, 
65% (n = 121) of participants notified a parent of their PID diagnosis, with a significantly 
higher parental notification rate among adolescents (14-17 years old) than young adults (18-
25 years old) (85.9% vs. 53.7%, p < 0.001). Among participants who notified a parent of 
their PID diagnosis, 74% reported parental engagement in their PID care. There was no 
statistically significant difference in parental notification between intervention and control 
group participants. Controlling for age and intervention group assignment, the Opportunity 




associated with parental notification. Participants who reported a greater sense of 
responsibility for the well-being of others (Opportunity for Nurturance subscale) were 17% 
less likely to notify a parent about their diagnosis (adjusted odds ratio [AOR] = 0.829 [95% 
CI: 0.707, 0.973]; p = 0.022). Participants who reported a greater sense that others 
recognized their competence, skills, and value (Reassurance of Worth subscale) were 20% 
more likely to inform a parent about their diagnosis (AOR = 1.197 [95% CI: 1.008, 1.422]; p 
= 0.040). Participants who reported a greater level of assurance that they could count on 
others for help (Reliable Alliance subscale) were 16% more likely to notify a parent about 
their PID diagnosis (AOR = 1.160 [95% CI: 1.023, 1.317]; p = 0.021). The presence or 
absence of statistically significant associations between perceived social support (SPS 
subscales) and received social support (parental engagement in PID self-care activities) were 
not reported. Further, the authors did not report the frequency of each supportive activity 
provided by parents and whether parental notification and/or parental engagement in self-
care were associated with increased participant adherence to PID treatment. 
Discussion 
The findings from this review of literature indicate that few studies have examined 
how young women cope with a PID diagnosis, or the role of social support after receiving a   
PID diagnosis. Only two published studies were relevant to the topics of interest. In the one 
paper that minimally covered coping with PID, the only coping strategy described was 
acceptance. However, acceptance pertained to expectations of the long-term sequela of 
infertility, not to the immediate PID diagnosis and treatment period. No studies specifically 
examined the coping strategies used by AYA diagnosed with and treated for PID. Further, 




among girls or women of any age. As such, there were no identified studies that used coping-
specific questions and/or validated instruments to evaluate coping with PID.  
While no published research has measured coping with PID, a few studies have 
examined AYA coping with related STIs (e.g., gonorrhea and chlamydia). The KIDCOPE, a 
10-item standardized instrument developed to assess coping with various kinds of problems, 
has been used to evaluate the coping strategies of adolescent girls in response to STI 
acquisition (Baker et al., 2001; Rosenthal, Biro, Cohen, Succop, & Stanberry, 1995). Each 
KIDCOPE item represented a different form of coping: blaming others, cognitive 
restructuring, distraction, emotional regulation, problem solving, resignation, self-criticism, 
social support, social withdrawal, and wishful thinking. Using a 4-point scale from 1 = “not 
at all” to 4 = “almost all the time,” study participants indicated how frequently they used 
each strategy. They utilized a 5-point scale ranging from 1 = “not at all” to 5 = “very much” 
to rate the helpfulness of the coping strategies they employed (Baker et al., 2001; Rosenthal 
et al., 1995). In a study of 177 adolescent girls (mean age = 16.8 years) with a history of at 
least one STI episode, the adolescents used a mean of 7.5 coping strategies. Wishful thinking 
was the most frequently reported coping strategy (95%), followed by problem solving (81%) 
and emotional regulation (79%). However, unlike problem solving and emotional regulation, 
frequency of wishful thinking use was not correlated with perceived helpfulness. Reasons for 
adolescents using a coping strategy they believed was unhelpful were not determined 
(Rosenthal et al., 1995).  
To extend Rosenthal and colleagues’ (1995) research on coping with STIs among 
adolescent girls, Baker et al. (2001) utilized the KIDCOPE to evaluate whether adolescent 




selected “other life stressor” was a moment during the previous six months when the 
adolescent was upset because of a friend. Wishful thinking (96%), blaming others (78%), and 
internal emotional regulation (72%) were the most frequently used coping strategies in 
response to STI acquisition. Self-blame was used more often in response to STI acquisition 
than in response to the interpersonal stressor (40% vs. 26%, p < 0.01), while problem solving 
was used less often (43% vs. 58%, p = 0.03). In response to STI acquisition, problem solving 
was positively correlated with perceived helpfulness (r = 0.73, p < 0.01), but the frequency of 
self-blame use was not correlated with perceived helpfulness (r = 0.01, p = 0.93). While 
study findings indicated that adolescent girls used some coping strategies differentially in 
response to STI acquisition compared to an interpersonal stressor, the sample size was too 
small (n = 67) to determine whether coping strategies varied by STI pathogen or STI history, 
or whether coping strategies were associated with future sexual health-related behaviors.  
Regarding social support for AYA diagnosed with PID, results from Munõz 
Buchanan et al. (2016) indicated that most young women with PID inform a parent of their 
diagnosis and receive supportive care from a parent. Believing that one could count on others 
for help and sensing that others recognized one’s competence were positively associated with 
parental notification of the PID diagnosis. Perceiving an increased sense of responsibility for 
the well-being of others was negatively associated with parental notification. To tailor the 
plan of care for a young woman diagnosed with PID, nurses and physicians should inquire 
about her access to supportive care and whether she is a parent or caregiver herself, since 
young women with a greater sense of responsibility for others were less likely to notify a 
parent of their diagnosis (and therefore more likely to manage PID self-care on their own) 




help for AYA receiving outpatient PID treatment and emphasizes the value of positive 
relationships with parents or other adults among AYA diagnosed with PID. While there is 
only one published study of social support for AYA diagnosed with PID, other studies have 
examined relationships between social support and STIs in AYA. However, the research 
related to social support and STIs among adolescents and young adults has pertained to 
seeking STI-related health care (Fortenberry & Zimet, 1999; Lowery, Chung, & Ellen, 2005), 
engaging in STI risk behaviors (Crosby et al., 2001; Crosby, DiClemente, Wingood, & 
Harrington, 2002; Mazzaferro et al., 2006), or self-reported STI history (Gao & Chen, 2011), 
not social support received after STI diagnosis and/or related to STI treatment adherence.  
While participants in all stages of adolescence were included in the study of 
perceived social support after receiving a PID diagnosis, the youngest participant in the study 
of perspectives on the impact of PID and coping strategies was 18 years old. Considering that 
at least 20 percent of PID cases in the United States occur in adolescents—who may not 
possess the developmental resources necessary to manage their self-care—and PID during 
adolescence increases vulnerability to long-term adverse reproductive health outcomes and 
negative health-related quality of life (Kelly et al., 2004; Trent et al., 2008; Trent et al., 2011; 
Trent, 2013), it is important to include younger adolescents in studies of psychosocial 
responses to PID.  
The paucity of published research also limited the description and discussion of 
diverse experiences with PID. The two studies included in this review of published research 
were conducted in only two countries: Australia and the United States. Most women (15 of 
23) in the Newton et al. (2014) qualitative study of women’s health care experiences with 




addition, the mean age of the study participants was more consistent with young adulthood 
than adolescence. The Munõz Buchanan et al. (2016) study of parental notification, 
perceived social support, and parental engagement in PID care among AYA was the only 
study conducted in the United States. The limited research conducted in the United States is 
problematic, considering the previously noted significant burden of PID among AYA in the 
United States. Regarding racial/ethnic representation in study participation, most (94%) 
participants in the Munõz Buchanan et al. (2016) study of perceived social support, parental 
notification, and parental engagement in the care of AYA diagnosed with PID were 
Black/African American. Participants in the large national randomized trial that guided the 
CDC guidelines on PID management (Ness et al., 2002) also were disproportionately 
Black/African American (i.e., 74.6% of outpatient treatment group and 74.8% of inpatient 
treatment group). Acknowledging that the lifetime self-reported history of PID diagnosis 
among non-Hispanic Black and non-Hispanic White sexually experienced women of 
reproductive age (18-44 years) in the United States with a previous STI diagnosis is nearly 
equal (10.0 % vs. 10.3%), it is important to include all groups affected by the disease 
(Kreisel, Torrone, Bernstein, Hong, & Gorwitz, 2017).  
While this is the first review to examine the roles of coping and social support in 
AYA with PID, our findings must be considered with several general limitations, including 
generalizability of results. It is likely that the study participants do not represent all AYA 
diagnosed with and treated for PID. Most participants (87%) in the Newton et al. (2014) 
qualitative study of women’s health care experiences with PID were recruited from one 
metropolitan sexual health clinic, whose patient population and health care delivery may 




(2016) study of parental notification, perceived social support, and parental engagement in 
PID care among AYA comprised a highly racially and socioeconomically homogeneous 
group recruited from one academic health center located in a single city with high STI 
prevalence. The few published studies about coping strategies and social support specific to 
PID diagnosis and treatment limit the conclusions that this review may provide, but it also 
indicates the need for additional research to strengthen the evidence. 
Clinical Implications 
 Treatment adherence is critical for preserving the health and quality of life of women 
diagnosed with PID. Evidence suggests that AYA women with PID often do not adhere to 
prescribed treatment guidelines, leaving them vulnerable to chronic pelvic pain, tubal 
infertility, ectopic pregnancy, and other adverse outcomes associated with unresolved or 
recurrent PID (Brunham et al., 2015; Greydanus & Dodich, 2015; Westrom, 1975). While 
quality improvement interventions that focus on clinician practices and theory-based 
interventions designed to change patients’ behaviors have achieved modest success in 
increasing the rates of women with PID who complete their medication regimen or return for 
follow-up care, overall adherence to treatment recommendations remains low. Psychosocial 
factors such as coping strategies and social support may influence a woman’s level of 
engagement in PID self-management. Evidence-based understanding of how AYA cope with 
a PID diagnosis and perceive and use available social support will inform the development of 
effective treatment and self-management plans tailored to the needs and available resources 
of the young women. The finding that young women who perceive a greater sense of 
responsibility for others are less likely to enlist the support of a parent to manage their PID 




resources and caregiver responsibilities when developing a plan of care. Through patient 
education and various forms of instrumental and emotional support, nurses have the capacity 
to provide strategies that enhance PID self-care and the prevention of PID recurrence and 
adverse reproductive health outcomes. 
Future Directions of Research  
The paucity of research on coping and social support associated with PID diagnosis 
and treatment provides limited evidence to inform clinical and community-based 
interventions to support the therapeutic trajectories of AYA diagnosed with PID. A limitation 
of the existing research is that it has focused on seeking and receiving care for PID, not 
subsequent self-care after PID diagnosis. Quantitative and qualitative studies conducted in 
diverse settings with diverse populations are needed to examine how adolescent and young 
adult women cope with PID to optimize treatment strategies and subsequent reproductive 
health outcomes. Current research suggests that AYA struggle with treatment adherence 
(Butz et al., 2016; Dunbar-Jacob et al., 2004) and have significant adverse reproductive 
outcomes associated with recurrent disease (Ness et al., 2002; Ness et al., 2005; Trent, Bass, 
Ness, & Haggerty, 2011; Trent et al., 2011). Structured questionnaires with validated 
instruments to measure coping are needed to identify the types of coping strategies used and 
factors associated with effective coping in PID-affected women, considering the negative 
impact on health-related quality of life associated with PID complications such as chronic 
pelvic pain (Haggerty, Schulz, & Ness, 2003). Questionnaires administered to larger and 
more diverse study populations in a variety of settings would provide robust evidence to 




perspectives via additional qualitative studies would further contextualize coping with PID 
and adherence to PID treatment guidelines.  
While Munõz Buchanan et al. (2016) determined that AYA who perceive that they 
can count on others for help or perceive that others recognize their competence are more 
likely to notify a parent about their PID diagnosis, and that most AYA who notified a parent 
about their PID diagnosis received supportive care from a parent, it is unclear whether 
perceived social support and parental engagement in care are associated with AYA adherence 
to PID treatment guidelines. Associations between perceived social support, specific 
supportive care received from parents, and adherence to the treatment regimen among AYA 
diagnosed with PID should be examined. Prior research has demonstrated the feasibility of a 
community-based nursing intervention to support AYA diagnosed with PID (Trent et al., 
2016). Investigation of psychological responses to the PID diagnosis and the relationships 
among coping strategies, social support, and subsequent self-care is needed to identify 
priorities for nursing interventions to promote positive health outcomes among young women 
diagnosed with PID.  
Conclusion 
Published studies provide limited information regarding coping strategies and social 
support within the context of PID diagnosis and treatment among AYA women. The dearth 
of research focused on coping with PID and related social support among AYA women 
presents an opportunity to examine the person-centered influences on self-management. 
Understanding the coping strategies and social support utilized by AYA women diagnosed 
with PID will inform nursing, other clinical, and public health interventions designed to 
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CHAPTER THREE: METHODOLOGY 
 This chapter describes the methodology of the current study, which employed a 
convergent mixed methods design to determine the influences of coping strategies and social 
support on PID self-care among young women. Quantitative and qualitative data were 
collected during the same period, each providing important insights pertaining to PID self-
care. The quantitative and qualitative data sets were analyzed separately and independently 
and then merged to compare, contrast, and synthesize the results (Creswell & Plano Clark, 
2011).  
Description of Parent Study 
Study data were collected from young women participating in Technology-Enhanced 
Community Health Nursing (TECH-N) (5R01NR013507, M. Trent, PI). As described in 
previously published research (Butz et al., 2016; Trent et al., 2016), TECH-N was a large 
RCT funded by the National Institute of Nursing Research (NINR) to evaluate an 
intervention consisting of daily medication reminders via text messaging and a follow-up 
clinical visit by a community health nurse (CHN) to improve clinical outcomes among young 
women diagnosed with mild to moderate PID. From September 2012 to December 2016, 
TECH-N study participants were recruited from the pediatric and adult emergency 
departments and a general pediatrics and adolescent medicine clinic at a large academic 
health center in Baltimore, Maryland. Patients enrolled in the study on the same day they 
were diagnosed with PID. Eligible participants were non-pregnant young women 13 to 25 
years old residing in the Baltimore, Maryland metropolitan area, diagnosed with mild to 




communicate in English or were admitted to the hospital to receive inpatient PID treatment 
were excluded from study participation.  
At baseline, all participants were tested for STIs (GC, CT, Mycoplasma genitalium, 
and Trichomonas vaginalis) and provided demographic, behavioral (e.g., medication self-
efficacy, sexual self-efficacy), social (e.g., perceived social support), and health history 
information via ACASI. Three to five days after study enrollment, participants in the 
intervention group met with the CHN at home or a mutually established location for a 
clinical assessment. All participants met with an outreach worker for follow-up study visits at 
14, 30, and 90 days. At the 14-day visit, participants were queried via structured face-to-face 
interview about medication adherence, partner notification and treatment, temporary 
abstinence from sexual intercourse, and social support received from parents/guardians 
during the treatment period. At the 30- and 90-day visits, participants were tested for STIs 
and completed an ACASI focused on health behaviors and symptoms. TECH-N study 
outcomes of interest included medication adherence, adherence to the 3- to 5-day clinical 
follow-up visit, and STIs at 90 days. The Johns Hopkins Medicine institutional review board 
(IRB) approved the TECH-N study. 
The current study used the TECH-N study population and data to investigate 
relationships among coping, social support, and PID self-management and to explore the 
experiences of young women diagnosed with and treated for PID. As indicated in Figure 3.1, 
data analyzed for this dissertation were collected from control and intervention group 
participants at the baseline, 14-day, and 30-day visits and from a subsample of control group 
participants who completed semi-structured interviews after the 90-day visit. Control group 




treatment. The current study did not assess the effects of the parent study intervention or the 
primary outcomes of the ongoing parent study. Additions made to TECH-N to conduct this 
study are outlined in blue in Figure 3.1 and described below. Approval from the Johns 
Hopkins Medicine IRB was obtained for the addition of the Brief COPE, an instrument to 
measure coping strategies, to the TECH-N 14-day visit protocol and for the conduct of semi-
structured in-person interviews after completion of the TECH-N 90-day visit to explore 
young women’s experiences with PID diagnosis and treatment. The current study includes 
participants who enrolled in the TECH-N study between June 2015 and December 2016, a 
period that commenced with the addition of the Brief COPE to the TECH-N protocol and 
concluded with the scheduled completion of TECH-N study enrollment.  
Dissertation Study Design 
Sampling and Sample Size 
The study sample to achieve Aims 1 and 2 consisted of non-pregnant young women 
13 to 25 years old residing in the Baltimore metropolitan area, diagnosed with mild to 
moderate PID, and receiving outpatient treatment for PID. Young women who were unable 
to communicate in English or were receiving inpatient PID treatment were excluded from 
study participation. The sample comprised a subgroup of TECH-N participants who 
completed the Brief COPE instrument at the 14-day visit interview. There were no additional 
exclusion criteria for the current study. The Brief COPE was added to the TECH-N protocol 
in June 2015. In consideration of TECH-N recruitment activity around that time, it was 
estimated that 100 participants would be enrolled in the study and complete the Brief COPE 
prior to TECH-N study completion. A priori power analyses were conducted for Aim 2 using 




behaviors among adolescent females, in which the odds of not using a condom during last 
sexual intercourse were 1.92 times greater among adolescent females who lacked social 
support (Crosby et al., 2002). The power calculations suggested that a sample size of 100 
would have at least 80% power to detect an OR of 1.92 or more at α = 0.05, using a binary 
logistic regression model. G*Power version 3.1.7 software was used for the power analysis 
(Faul, Erdfelder, Buchner, & Lang, 2009). Despite a continuous effort to reach 100, the final 
sample size for Aims 1 and 2 was 90 participants. 
To achieve Aim 3, the sample consisted of young women 13 to 25 years of age who 
received standard of care treatment for mild to moderate PID, selected from the cohort of 
TECH-N control group participants who completed the 90-day protocol visit. Purposive 
sampling of control group participants was used to explore young women’s experiences with 
PID that were not potentially influenced by the TECH-N intervention. Considering the 
limited research on young women’s experiences with PID, the phenomenon of PID self-
management among young women who received standard of care treatment may be of 
broader clinical interest than the enhanced experiences specific to the TECH-N intervention. 
The demographic characteristics of the qualitative interview sample were expected to be 
consistent with that of the parent study population: largely black/African American, non-
Hispanic, low-income women. Due to the relative homogeneity of the sample in terms of 
race, ethnicity, and socioeconomic status, efforts were made to maximize variation by age 
group and explore the PID-related experiences among younger (adolescents aged 13-19 
years) and older (young adults aged 20-25 years) participants. Adolescents diagnosed with 
PID are at increased risk for subsequent STIs (Trent et al., 2011), which suggests that 




counterparts. Participants were recruited until qualitative data saturation occurred; interview 
data were analyzed after each interview, and subsequent interviews were conducted and 
analyzed until no new themes emerged from the data. Qualitative data saturation was reached 
with 18 interviews, a sample size approximating previously published qualitative research on 
women diagnosed with PID (Newton et al., 2014).  
Participant Recruitment and Enrollment 
Study participant recruitment and enrollment for Aims 1-2 has been described in 
previously published manuscripts about the TECH-N parent study (Butz et al., 2016; Trent et 
al., 2016). For Aim 3, young women between the ages of 13 and 25 years, who were 
diagnosed with and treated for mild to moderate PID at the pediatric emergency department, 
adult emergency department, or pediatric and adolescent medicine clinic of Johns Hopkins 
Hospital within the five years preceding the study were eligible for study participation. 
Young women were recruited from the control group of TECH-N. The TECH-N study had 
IRB approval for continued participant contact beyond the initial 90 days, and IRB approval 
was obtained for the qualitative research phase of this study. Potential study participants were 
contacted after completion of the 90-day TECH-N protocol visit. Each participant provided 
written informed consent prior to the initiation of research study activities.  
Data Collection 
For Aims 1-2, demographic, behavioral, social (e.g., perceived social support), and 
health history information were collected during the baseline visit via ACASI. Follow-up 
data on self-care behaviors and received social support were collected via structured 




study identification number; personally-identifiable information was removed to ensure 
confidentiality. 
Using a qualitative descriptive approach (Sandelowski, 2000), data collection for Aim 
3 consisted of one-time, in-person, semi-structured interviews, each approximately 30 
minutes (mean = 31.6 minutes) in duration. Using open-ended questions developed with and 
organized by TMSC constructs, interviews were conducted between January 2017 and April 
2017 to explore the experiences of young women diagnosed with and treated for PID. After 
providing informed consent, participants completed a brief demographic and health history 
questionnaire, which was verbally administered by the interviewer. The semi-structured 
interview was conducted immediately after completion of the questionnaire. Interview 
questions inquired about topics including the overall experience with PID, thoughts and 
feelings about the PID diagnosis, coping with the PID diagnosis, social support received after 
the PID diagnosis, and PID self-management. The questionnaire and interview guide are 
included in the Appendix. The interviewer allowed flexibility for the interview participants to 
describe their experiences with PID diagnosis and treatment, following up with questions and 
probes as needed to explore and clarify the participants’ descriptions. Interviews were 
conducted in an office space on the Johns Hopkins campus that provided privacy. Interview 
participants were assigned an identification number, and true names or identifying 
information were removed from interview transcripts. Participants received $40.00 for their 
study participation after completing the interview. Interviews were audio recorded and 
transcribed verbatim. Written field notes were recorded during and after the interviews to 




reviewed after each interview to determine data saturation and to add reflexivity (i.e., 
interview guide revisions) prior to the next interview.  
Research Variables, Timing of Collection, Definitions, and Measurement 
Measures collected at baseline included demographics (e.g., age, race/ethnicity, 
family/household composition), reproductive and sexual history, and perceived social 
support. Perceived social support was measured by the Social Provisions Scale (SPS). The 
SPS contains 24 items, with four items to measure each of the following six social provision 
dimensions: attachment (emotional closeness from which one derives a sense of security), 
social integration (a sense of belonging to a group that shares similar interests, concerns, and 
activities), reassurance of worth (recognition of one’s competence, skills, and value by 
others), reliable alliance (the assurance that others can be counted on for tangible assistance), 
guidance (advice or information from parental figures, etc.), and opportunity for nurturance 
(the sense that others rely upon one for their well-being) (Cutrona & Russell, 1987). Using a 
scale from 1 (“strongly disagree”) to 4 (“strongly agree”), respondents indicated the extent to 
which each item statement described their current relationships with other people (Cutrona & 
Russell, 1987). SPS scores were determined by calculating the sum totals for each 
dimension’s subscale and the total over all subscales. Higher scores indicated greater levels 
of perceived social support. Possible scores ranged from 4 to 16 for each SPS subscale, and 
24 to 96 for the overall SPS total. As shown in Table 3.1, internal consistency reliability of 
the total SPS score is excellent (α = .915), with alpha coefficients on the individual scales 
ranging from .653 to .760 (Cutrona & Russell, 1987). In this study, Cronbach’s alpha for the 
total SPS was .89, and ranged from .52 to .78 for SPS subscales. The SPS instrument is 




Follow-up measures included parental notification, received social support, and PID 
self-care behaviors (at 14 days and 30 days). To measure received social support, participants 
were asked to indicate the types of support their parents/guardians provided after their 
diagnosis (i.e., provided comfort, offered advice, reminded them to take their medications, 
took them to follow-up appointments, encouraged them to talk to their partners, or other). 
This study examined a new variable, coping strategy, as measured by the Brief COPE 
(Carver, 1997). The Brief COPE, an abbreviated version of the COPE Inventory, is a 28-item 
instrument used to measure several ways in which people respond to stress. The 14 scales of 
the Brief COPE measure the following coping strategies: self-distraction (engaging in 
activities to take one’s mind off the stressor), active coping (taking active steps to remove a 
stressor or to ameliorate its effects), denial (refusal to believe that the stressor exists), 
substance use (using alcohol or drugs), use of emotional support (using moral support, 
sympathy, or understanding), use of instrumental support (using advice, assistance, or 
information), behavioral disengagement (reducing effort to handle the stressor), venting 
(expressing feelings of distress or upset one is experiencing), positive reframing (managing 
emotional distress rather managing the stressor), planning (thinking about how to manage a 
stressor), humor (making fun of the stressful situation), acceptance (belief in the reality of a 
stressful situation), religion (reliance on religion during a stressful time), and self-blame 
(blaming self for the stressful situation). Active coping, use of instrumental support, and 
planning are problem-focused coping strategies, while the remaining coping strategies are 
emotion-focused (Carver, Scheier, & Weintraub, 1989). The frequency of use for each 
coping strategy item is measured on a 4-point scale, from 1 (“I haven’t been doing this at 




the mean for each scale. Possible Brief COPE scores range from 1 to 4. A higher score 
indicates a more frequent use of the coping response. According to the author of the Brief 
COPE, there is no comprehensive score for this measure, and investigators may selectively 
use the subscales of greatest interest to their research (Carver, 1997). As shown in Table 3.1, 
internal reliability of the Brief COPE subscales ranges from .50 to .90 (Carver, 1997). 
Cronbach’s alpha in this study ranged from .54 to .93, except acceptance (.27) and self-blame 
(.49). The Brief COPE instrument is shown in the Appendix.  
Data Analysis Plan 
To achieve Aim 1, coping strategies were operationalized as Brief COPE scales and 
descriptively summarized, using frequencies, means, and standard deviations. Types of 
perceived social support were operationalized as SPS subscales at baseline, and types of 
received social support were operationalized as parental support reported at follow-up. Social 
support was descriptively summarized using frequencies, means, and standard deviations.  
Data analysis for Aim 2 was performed using Stata I/C, version 15 (StataCorp LP, 
College Station, TX). Logistic regression was used to analyze relationships between PID 
self-management behaviors and perceived social support, received social support, and use of 
coping strategies. The PID self-management behavior outcomes of interest were medication 
completion, clinical follow-up visit attendance, partner notification, and sexual abstinence. 
Multiple logistic regression models were constructed for each PID self-management behavior 
outcome and social support or coping strategy variable, adjusting for age, STI history, health 
insurance coverage status, and group assignment. Selected covariates were consistent with 
previously published PID self-management research (Trent et al., 2010). Group assignment 




the parent study intervention aimed to improve adherence to the PID treatment 
recommendations analyzed in this study. Because clinical follow-up assessment was a 
principal component of the parent study intervention (i.e., all intervention group participants 
received a community-based clinical follow-up visit), clinical follow-up visit attendance was 
analyzed only for control group participants, and group assignment was not included as a 
covariate in multiple logistic regression models to analyze clinical follow-up visit attendance. 
A significance level of α = 0.05 was used for all analyses. Adjusted odds ratios (AORs) and 
corresponding 95% confidence intervals (CIs) were reported. To test Hypothesis 2.1, 
bivariate logistic regression analyses were used to screen candidate variables for multiple 
logistic regression modeling, and multiple logistic regression modeling was used to 
determine whether young women who reported greater use of problem-focused coping 
strategies were more likely to report engagement in PID self-management behaviors, 
controlling for age, STI history, health insurance coverage status, and group assignment. To 
test Hypothesis 2.2, multiple logistic regression analyses were conducted to determine 
whether young women who reported higher levels of social support were more likely to 
report engagement in PID self-management behaviors, controlling for age, STI history, 
health insurance coverage status, and group assignment. To test Hypothesis 2.3, social 
support and coping strategy variables with p-values < 0.10 in multiple logistic regression 
models were selected to create two-way interaction terms to test the moderating effect of 
social support on the relationship between coping strategies and PID self-management 
behaviors.  
The data analysis approach to achieve Aim 3 was qualitative content analysis, defined 




systematic classification process of coding and identifying themes or patterns” (Hsieh & 
Shannon, 2005, p. 1278). The audio recording of each interview was reviewed, and general 
impressions of the interview and noteworthy statements by the participant were documented. 
The accuracy of all interview transcripts was verified by comparing them to the original 
audio recordings, and transcripts were read in their entirety to yield a sense of participants’ 
experiences. Transcripts and field notes were analyzed after each interview to determine data 
saturation and to add reflexivity (i.e., modification of interview guide questions) prior to the 
next interview. Verified transcripts were imported into a qualitative research software 
program, f4analyse, for data management and analysis. Transcribed text related to the focus 
of the research was selected and grouped by shared characteristics. Codes were generated 
inductively from the data and from TMSC constructs. Groups of repeating codes or ideas 
were aggregated into themes. Field notes recorded during the interviews were incorporated 
into the analyses. Interviews were analyzed throughout the data collection process; therefore, 
codes, categories, and themes that appeared not to be fully developed in initial interviews 
were made richer through modifications to the interview guide. The doctoral candidate 
carried out the principal analysis. Procedures to enhance validity included dual coding and 
modified member checking (Denzin & Lincoln, 2000). All transcripts were read to create a 
codebook for relevant text data. A second coder independently coded data by applying the 
codebook to three transcripts, and the finalized codebook was confirmed by discussion and 
consensus between the coders. The doctoral candidate and second coder coded three 
additional transcripts using the finalized codebook, for a cumulative 33% of transcripts 




Data Integration Plan 
This study employed a convergent mixed methods design. Quantitative and 
qualitative data were collected and examined separately, and then integrated through 
narrative at the data interpretation level (Fetters, Curry, & Creswell, 2013). Information from 
the quantitative and qualitative research phases were weighted equally. The results of 
quantitative analyses were compared with themes that emerged from the qualitative data. 
Data integration was achieved by reporting the merged results together as quantitative results 
followed by participant quotes or qualitative themes that complement the quantitative results. 
Divergent or inconsistent findings were reported with suggested explanations.  
Inclusion of Children 
The current study included female children younger than 18 years old who were 
diagnosed with mild to moderate PID, because children were part of the target age range for 
the TECH-N study (13-25 years old). At least 20% of PID cases diagnosed each year in the 
United States occur in adolescents (≤ 19 years old) (Greydanus & Dodich, 2015). Therefore, 
it is important to include children in studies of PID to identify age-appropriate, effective 
interventions to prevent adverse reproductive health outcomes for young women so early in 
their reproductive life course.  
Study recruitment sites were facilities designed to serve children, adolescents, and 
young adults. Participants and TECH-N staff mutually agreed upon appropriate, safe 
locations for study follow-up visits. Qualitative interviews were conducted in an office space 
on the campus of an academic health center to allow for safeguarding the privacy of 
interview participants. With 29 participants who were younger than 18 years old (32%), this 




influences of coping strategies and social support on self-care behaviors among adolescents 
and young adult women with PID. 
A waiver of parental consent was granted for participation in TECH-N—the parent 
study for this dissertation study—as participants are seeking care for services under the 
Maryland minor consent law. However, all study participants were encouraged to discuss 
their participation with a parent, guardian, and/or trusted adult. There were no adverse events 
related to the TECH-N study using this approach to research with children and/or parental 
engagement to support the research.  
Inclusion of Women and Minorities 
All 90 subjects in this study were female. PID is a disease exclusive to females; 
therefore, males were excluded from TECH-N and the current study. The planned racial 
distribution of subjects was 96% Black or African American and 4% White. The planned 
ethnic distribution of subjects was 6% Hispanic or Latino and 94% Not Hispanic or Latino. 
TECH-N and the current study recruited all young women residing in Baltimore within the 
target age range, regardless of race/ethnicity. African American women are 
disproportionately affected by PID (Kreisel, Torrone, Bernstein, Hong, & Gorwitz, 2017), 
thereby justifying the planned enrollment. Considering previous research experience in this 
geographic area and the study sites, at least 90% of the young women enrolled in TECH-N 
and this study were projected to be of African American descent. Cumulative enrollment for 
this study was 90% Black or African American, 3% White, and 4% more than one race. 




Protection of Human Subjects 
The current study was conducted within the existing infrastructure of an active 
randomized controlled clinical trial, the TECH-N study. The following will describe details 
of TECH-N that were pertinent to the current study, as well as additional elements relevant to 
the qualitative phase of the current study. 
Risks to Human Subjects  
Human Subjects Involvement, Characteristics, and Design  
Subject Population. Ninety adolescents and young adult women aged 13-25 years 
diagnosed with mild to moderate PID at an academic health center in Baltimore, Maryland 
were enrolled in the current dissertation study. Children were involved in the study because 
at least 20% of PID cases diagnosed each year in the United States occur in adolescents (≤ 19 
years old) (Greydanus & Dodich, 2015). It is important to include children in studies of PID 
to identify age-appropriate, effective interventions to prevent adverse reproductive health 
outcomes for young women so early in their reproductive life course.   
Sampling Plan, Recruitment, and Retention Strategies. Adolescents and young 
adult women with mild to moderate PID were recruited from a large academic health center 
by the TECH-N research study staff at the time of PID diagnosis. Clinical sites included the 
adult and pediatric emergency departments and the general pediatrics and adolescent 
medicine clinics. Research staff were available on-site and accessible via pager to facilitate 
patient referral and recruitment. Research staff recorded all patients approached for study 
participation, documenting all referrals, eligible participants, consenting participants, and 
refusals. To facilitate study participant retention, detailed contact information was obtained 




numbers, cell phone numbers, e-mail addresses, school attended, and the contact information 
for two individuals who would always know the participants’ whereabouts and could be 
contacted to locate them. Participants were advised to call the TECH-N office if there were 
changes in their contact information, and they received a $5 gift card incentive for 
notification of contact information change. The TECH-N target population resided in 
Baltimore City at the time of PID diagnosis, but young women who resided in the Baltimore 
metropolitan area, including surrounding counties, were eligible for study participation. 
Inclusion and Exclusion Criteria. Young women 13 to 25 years old, diagnosed with 
mild to moderate PID, given an outpatient treatment disposition, permanently residing in the 
Baltimore metropolitan area, and willing to sign informed consent were eligible for study 
inclusion. Informed consent entailed willingness to complete study procedures, which 
included randomization and community-based follow-up by the TECH-N team. Patients who 
were pregnant, had a concurrent diagnosis of sexual assault, or were unable to communicate 
with staff or use a cell phone due to cognitive limitations, mental disabilities, or English 
language barriers were ineligible for study participation. 
Enrollment, Consent, and Treatment. Recruiters were on-site at the clinical 
facilities to recruit patients diagnosed with PID at the time of diagnosis. Patients were 
screened for eligibility criteria, and then recruited for study participation if eligible. Prior to 
enrollment, study details were reviewed as a part of the informed consent process performed 
by the recruitment staff. All patients who agreed to participate completed an audio 
computerized assisted self-interview (ACASI) to collect baseline information and then were 
randomized to the control or intervention study arm. The ACASI interview was 




completion of initial TECH-N study procedures and instruction, patients received 
remuneration of $10 and a 14-day course of antibiotics consistent with the CDC treatment 
guidelines to be dispensed by the clinician prior to discharge according to Maryland law and 
hospital policy. 
Qualitative Data Collection. One phase of this study comprised a qualitative 
exploration of the experiences of young women diagnosed with and treated for PID within 
the preceding five years. Young women assigned to the control arm of TECH-N were 
recruited for participation in the qualitative phase of the study. This sampling strategy 
allowed for in-depth exploration of young women’s experiences with PID standard of care 
treatment. At the completion of the 90-day visit, the TECH-N outreach worker asked control 
group participants if they were interested in participating in an in-depth interview. 
Participants who expressed interest were contacted to receive additional information about 
the interview and for recruitment into the qualitative study. The TECH-N study had IRB 
approval for continued participant contact beyond the initial 90 days, and participants could 
indicate their willingness to be contacted for future research studies on the original TECH-
N consent form. IRB approval was obtained to conduct the qualitative phase of the research 
study. During the study recruitment process, the young women were assured that their 
participation would be strictly voluntary, they could stop at any time, and their study 
participation decision would not affect their current and/or future care at the academic health 
center. Interviews were conducted in a space that would allow for the protection of the 
participant’s privacy, where only the participant and interviewer would be present. After 
providing informed consent, participants completed a brief demographic and health history 




interview was conducted immediately after completion of the questionnaire. The interviews 
were audio recorded with a digital recorder, and written field notes were documented. Audio 
recorded interviews were transcribed. Each participant was assigned a unique study 
identification (ID) number; personally-identifiable information was not recorded. Participants 
received $40.00 after they completed the study visit. Data saturation was reached with 18 
interviews, a sample size that was consistent with previously published qualitative research 
on women diagnosed with PID (Newton et al., 2014). 
Sources of Materials  
Information regarding demographics, sexual history, attitudes, perceptions, and 
sexual risk behaviors was collected from participants using ACASI and face-to-face 
interviews, both structured and semi-structured. ACASI interview data were automatically 
uploaded to a secure server for warehousing in the central database. Participant records were 
stored in locked filing cabinets in the locked TECH-N office. All data were linked to 
participants through a study ID number. Electronic recordings of qualitative interviews were 
stored on password-protected media and did not include identifying information. The link 
between identifying information and study ID number were kept in the project manager’s 
locked filing cabinet. To identify and recruit control group participants eligible for the 
qualitative phase of the study, study team members had access to individually identifiable 
private information. No persons other than study team members had access to individually 
identifiable private information.  
Potential Risks  
There were no significant physical, psychological, financial, legal, or other risks 




to recruitment for the qualitative interview, it was not anticipated that participants would 
experience distress during the qualitative interview focused on experiences with PID. If a 
participant had expressed a clinical concern and/or emotional distress during the study visit, 
she would have been referred to a clinician associated with the academic health center for 
management of reproductive health concerns and/or to her primary care provider for 
additional services. The general pediatrics and adolescent medicine clinic staff members 
were available to provide social work and mental health referral services as needed.  All 
interviews were conducted on the campus of the academic health center; therefore, security 
for study participants and the research team was provided by the campus security team. The 
potential for breaches of confidentiality was miniscule given the limited number of personnel 
with access to participant information.  
Adequacy of Protection Against Risks  
Recruitment and informed consent. Clinical staff referred potential participants to 
the study by notifying TECH-N staff of adolescent and young adult female patients 
diagnosed with mild to moderate PID. After the TECH-N team member determined that the 
patient was eligible for study participation, she met with the patient in a private space 
(emergency department or clinic examination room) to ask the patient if she was willing to 
participate in the study. Patients who agreed to participate in the study received a detailed 
review of the study by a TECH-N team member, including information that their 
participation in the study would have no effect on subsequent medical care at any referral 
site. TECH-N participants provided written documentation of informed consent. The TECH-
N team obtained a waiver of parental consent from the Johns Hopkins Medicine IRB for 




to research participation while receiving reproductive health care. Further, most adolescents 
seen in ambulatory sites for PID at Johns Hopkins seek care while unaccompanied by a 
parent.  
For the qualitative interview phase, TECH-N control group participants were 
contacted after completion of the 90-day visit via telephone, e-mail, and/or mail to inform 
them of the qualitative research. Participants who expressed interest in being interviewed 
were scheduled to meet in a private office space on the Johns Hopkins campus for a detailed 
explanation of the study and the informed consent process. Participants who consented to the 
interview provided written documentation of informed consent. Parental consent was not 
required for participation, because the interview pertained to confidential sexual health 
services. According to Maryland law, a minor has the same capacity as an adult to consent to 
treatment for or advice about venereal disease [Md. Code Ann., Health-Gen. II § 20-
102(c)(1)-(5)]. Under 45 CFR § 46.408 (c), an IRB may waive parental consent requirements 
if it determines that a research protocol is designed for conditions for which parental or 
guardian permission is not a reasonable requirement to protect the subjects, an appropriate 
mechanism for protecting the children who will participate as research subjects will be 
substituted, and the waiver is not inconsistent with Federal, state, or local law. Furthermore, 
Maryland law allows for parental bypass in situations of minimal risk and when the burden 
of getting consent would cause more harm than good. It was asserted that: 1) Many of the 
issues which were surveyed constituted health problems for which adolescents can seek 
health care under state regulations without parental consent, thereby making the CFR 
requirement for parental permission less applicable (45 CFR § 46.402 [a]); 2) Since the 




seeking permission from parents for adolescents to participate in this interview would 
represent an automatic disclosure of confidential medical information via the consent form 
and therefore would violate the Maryland Minor Consent Law [Md. Code Ann., Health-Gen. 
II § 20-102(c)(1)-(5)]; 3) The requirement of parental consent would impose undue burden 
on potential participants given their right to privacy related to past sexual behavior and care.   
Protections against risk. Only members of the TECH-N evaluation team—all 
formally trained and committed to confidentiality and protection of patient rights—had 
access to patient charts and data extraction forms. No identifying patient data have been or 
will be included in any presentations or publications generated from this study. All TECH-N 
participants were assigned a unique study ID number to avoid the inclusion of personally 
identifying information in the TECH-N database. The TECH-N study design provided 
several alternatives for study participation that allowed adolescents to make decisions about 
non-participation, participation with parental awareness or involvement, and participation 
through alternate community outreach strategies. By offering these alternative strategies, our 
team ensured protection of privacy as afforded by law while setting the stage for adult 
involvement that could potentially facilitate improved clinical outcomes for the patient. The 
TECH-N team documented the participation strategies and evaluated potential variations in 
observed effects based on follow-up approach. To protect the privacy of participants, 
interviews were conducted in a space that ensured privacy. 
Potential Benefits of the Research to Human Subjects and Others  
Participants may or may not have directly benefitted from participation in this study, 
which aimed to identify opportunities for future intervention to enhance PID self-care 




negative reproductive health sequelae. Participants who engaged in the qualitative interviews 
may have found the interviews to be a beneficial opportunity to discuss their health care 
experience and the issues they encountered in greater depth. The previously mentioned 
minimal risks were reasonable in relation to the anticipated benefits to research participants 
and others.  
Importance of the Knowledge Gained  
Treatment of existing PID episodes and the prevention of future STIs and PID 
recurrence are critical to reducing the risk of long-term reproductive health complications 
such as tubal infertility and ectopic pregnancy. This study contributes to the existing 
knowledge of PID self-care among young women by exploring the context of PID self-care 
and examining psychosocial factors not addressed in previous studies. Exploring the context 
of PID self-care behaviors would identify potential opportunities for intervention. Examining 
psychosocial factors, such as coping and social support, that may influence PID self-care 
would (1) help clinicians understand, support, and promote self-care among adolescents and 
young adult women diagnosed with PID, and (2) inform the development of interventions 
that promote coping strategies and types of social support associated with PID self-care. The 
minimal risks of participation in this study were reasonable in relation to the importance of 
the knowledge that may be gained; knowledge gained from this study will advance the 
identification of priorities to support adolescents and young adult women diagnosed with PID 
and preserve their reproductive health. 
Data and Safety Monitoring Plan  
For quality and safety monitoring of the study, the doctoral candidate met monthly 




data collection issues, participant safety, and responses to participants’ concerns. She had 
access to her sponsor and co-sponsor for assistance at any time if she was unable to respond 
adequately to a participant concern. As a clinical trial, the TECH-N parent study had a data 
safety monitoring board consisting of a seasoned clinical trial researcher (Cynthia Rand, 
PhD, Professor, Johns Hopkins University), an adolescent medicine clinician-scientist 
focused on STI research (Lydia Shrier, MD, MPH, Assistant Professor, Harvard School of 
Medicine), and a clinician-researcher whose research has focused on treated young women 
with chronic pelvic pain (Peter Rowe, MD, Professor, Johns Hopkins School of Medicine). 
Bi-annual data reports generated by the TECH-N biostatistician/data manager were submitted 
to DSMB team members for review, with written responses requested from each member 
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Study Objective: To identify social support and coping strategies used by young women 
diagnosed with pelvic inflammatory disease (PID) and examine their associations with PID 
self-management. 
Design, Setting, Participants, Interventions and Main Outcome Measures: Young 
women 13-25 years old diagnosed with PID in an urban academic health center emergency 
department or pediatric clinic (n=90; mean age=19.2 years) completed surveys to assess 
baseline perceived social support (Social Provisions Scale), and post-diagnosis coping 
strategies (Brief COPE), received social support, and PID self-management behaviors 
(medication completion, clinical follow-up visit attendance, partner notification, and sexual 
abstinence) at follow-up.  Multiple logistic regression was used to analyze associations of 
social support and coping with PID self-management behaviors.  
Results: The highest perceived social support was guidance (mean = 12.3, standard deviation 
[SD]= 2.4). Medication reminders were the most commonly received support (48.9%). 
Acceptance (mean = 3.5, SD = 0.72) and active coping (mean = 3.5, SD = 0.77) were the 
most frequently used coping strategies. Coping strategies and received social support were 
not associated with PID self-management. The social provision of opportunity for nurturance 
(perceived responsibility for others) was associated with medication completion (adjusted 
odds ratio [AOR]=1.26, 95% CI: 1.00-1.59, p=0.05) and clinical visit attendance 
(AOR=2.43, 95% CI: 1.19-4.93, p=0.01). 
Conclusions: Most young women with PID used problem-focused coping strategies after 




and clinical visit attendance, but coping strategies and received social support were not 
associated with adherence to PID treatment recommendations.  
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Treatment regimens recommended by the Centers for Disease Control and Prevention 
(CDC) for mild to moderate pelvic inflammatory disease (PID) include a 14-day course of 
outpatient oral antibiotic therapy and pain management, sex partner notification for sexually 
transmitted infection (STI) treatment, sexual abstinence until patient and partner are treated, 
and a follow-up evaluation within 72 hours of diagnosis to assess patient for clinical 
improvement (Centers for Disease Control and Prevention, 2015). Although large 
randomized clinical trials such as the Pelvic Inflammatory Disease Evaluation and Clinical 
Health (PEACH) trial have demonstrated that more expensive inpatient antibiotic treatment 
does not afford additional clinical efficacy compared to outpatient antibiotic treatment for 
mild to moderate PID (Ness et al., 2002), adherence to the CDC-recommended outpatient 
treatment regimen remains suboptimal (Trent, 2013). A PEACH trial analysis of medication 
adherence using electronic event monitoring demonstrated that women took an average of 
70% of prescribed doses of doxycycline and took the prescribed two daily doses for less than 
50% of outpatient treatment days (Dunbar-Jacob, Sereika, Foley, Bass, & Ness, 2004). 
Approximately 15% of PEACH trial participants reported failure to abstain from sexual 
intercourse during the PID treatment period, and approximately 29% reported that their 
partners received STI treatment after they were diagnosed with PID (Trent et al., 2011). 
Compared to their older counterparts, young women diagnosed with PID are at 
increased risk for subsequent STIs and PID, and adverse reproductive health outcomes 
(Kelly, Ireland, & Aughey, 2004; Trent, Chung, Forrest, & Ellen, 2008; Trent et al., 2011; 
Trent, 2013). For example, 20% of adolescent PEACH study participants tested positive for 




separate study of adolescents who received outpatient treatment for PID, 34% were 
diagnosed with chlamydia, gonorrhea, and/or PID during the 48-month follow-up period 
(Trent et al., 2008). Kelly et al. (2004) conducted a retrospective chart review of young 
women 13-23 years old diagnosed with PID at an urban teen clinic and found that 23% of the 
young women did not adhere to the medication regimen and sexual abstinence 
recommendations. Young women with one PID episode were 1.44 times more likely than 
young women with recurrent PID to report adherence to treatment recommendations. 
Acknowledging the limitations of retrospective chart reviews, including the accuracy and 
thoroughness of clinical documentation and patient self-report, the study results suggest that 
young women with multiple PID episodes were less adherent to treatment and self-
management recommendations than their single-episode peers.  
A quality improvement intervention for the outpatient management of PID in 
adolescents increased the proportion of emergency department and clinic patients who 
returned for follow-up care within 72 hours from 10% to 43%. However, 57% of patients did 
not follow up for care, and almost 40% of patients had not completed taking their 
medications at two weeks (Trent, Judy, Ellen, & Walker, 2006). In a randomized controlled 
trial of a brief video behavioral intervention for adolescents with mild to moderate PID, only 
24% of all patients returned for a 72-hour follow-up clinical visit, and almost one-third of all 
participants did not adhere to the medication regimen, with no statistically significant 
differences between the intervention and control groups (Trent, Chung, Burke, Walker, & 
Ellen, 2010). The limited improvements in outpatient treatment adherence generated by 
clinical quality improvement and behavioral interventions suggest that factors beyond 




Coping strategies and social support are two psychosocial factors that may 
significantly influence PID self-care behaviors among young women. Coping, defined as 
cognitive and behavioral efforts to manage specific external and/or internal demands 
appraised as taxing or exceeding the resources of the person, is the attempt to manage 
psychological stress (Glanz, Rimer, & Viswanath, 2008). Problem-focused coping involves 
approaching the problem and making active efforts to resolve the problem, while emotion-
focused coping includes trying to avoid the problem and focusing on managing the emotions 
associated with it (Zeidner & Endler, 1996). Social support, or help obtained from others, is a 
resource for coping and commonly indicated as a strategy on coping instruments (Carver, 
Scheier, & Weintraub, 1989; Carver, 1997; Glanz et al., 2008; Spirito, Stark, & Williams, 
1988). The Transactional Model of Stress and Coping, developed by Lazarus and Cohen, 
posits that stressful experiences are construed as person-environment transactions, in which 
the impact of an external stressor, or demand, is mediated by the person’s appraisal of the 
stressor (primary appraisal) and the psychological, social, and cultural resources at the 
person’s disposal (secondary appraisal). Coping mediates the emotional and functional 
effects of primary and secondary appraisals, and social support moderates the effects of 
coping strategies on outcomes. Outcomes include health behaviors such as treatment 
adherence (Glanz et al., 2008). The ways that individuals experience and cope with stress 
may influence how they seek health care and social support, as well as their adherence to 
health care professionals’ treatment recommendations and follow-up visits (Glanz et al., 
2008). During adolescence, individuals move toward independence and autonomy in 




upon parents decreases, the family remains a critical source of support during this period, 
including during times of illness (Muuss, Velder, & Porton, 1996). 
There is a dearth of research on coping strategies and social support among young 
women diagnosed with PID, but a small body of research on coping strategies and social 
support within the context of related STIs has been published. Young women use multiple 
coping strategies in response to an STI diagnosis, and the coping strategies differ from the 
strategies utilized in response to other interpersonal stressors (Baker et al., 2001; Rosenthal, 
Biro, Cohen, Succop, & Stanberry, 1995). Problem-focused coping has been positively 
associated with more consistent condom use one month after a chlamydia or gonorrhea 
diagnosis (Schwartz et al., 2008). Social support has been positively associated with STI-
related care seeking (Fortenberry & Zimet, 1999), medication adherence (Scheurer, 
Choudhry, Swanton, Matlin, & Shrank, 2012), and protective sexual behaviors, such as 
consistent condom use and secondary abstinence (Crosby et al., 2001; Crosby, DiClemente, 
Wingood, & Harrington, 2002; Fortenberry & Zimet, 1999; Mazzaferro et al., 2006).  
Preliminary analysis from a randomized controlled trial of a technology-enhanced 
community nurse intervention to prevent recurrent STIs after a PID diagnosis indicated that 
65% of young women with PID notified a parent of their diagnosis, and 74% of the young 
women who notified their parents received support such as advice, comfort, and medication 
reminders. Young women who reported a greater sense of responsibility for the well-being of 
others were less likely to notify a parent of their PID diagnosis. Young women who reported 
a greater sense that they could rely on others, or a greater sense that others recognized their 
competence and personal qualities were more likely to notify a parent of their PID diagnosis 




self-management were not examined. The objectives of this study were to identify the social 
support and coping strategies used by young women in the immediate interim after a PID 
diagnosis and to examine the effects of social support and coping strategies on PID self-
management. It was hypothesized that social support and problem-focused coping strategies 
would be positively associated with PID self-management, and that social support would 
moderate the effects of coping strategies on PID self-management.  
Materials and Methods 
This study is an analysis of a subsample of participants in the Technology-Enhanced 
Community Health Nursing (TECH-N) study. As described in previously published research 
(Butz et al., 2016; Trent et al., 2016), TECH-N was a randomized controlled trial to evaluate 
an intervention consisting of daily medication reminders via text messaging and a follow-up 
clinical visit by a community health nurse (CHN) to improve clinical outcomes among young 
women diagnosed with mild to moderate PID. Study participants were recruited from the 
pediatric and adult emergency departments and a general pediatrics and adolescent medicine 
clinic of an academic health center, enrolling in the study on the same day they were 
diagnosed with PID. Eligible participants were non-pregnant young women aged 13 to 25 
years residing in the Baltimore, Maryland metropolitan area, diagnosed with mild to 
moderate PID, and receiving outpatient PID treatment. Young women who were unable to 
communicate in English or were admitted into the hospital to receive inpatient PID treatment 
were excluded from study participation. This analysis includes participants who enrolled in 
the TECH-N study between June 2015 and December 2016; this period commenced with the 
addition of an instrument to measure coping to the TECH-N protocol and concluded with the 




assisted self-interview (ACASI) at baseline and one month, and via structured face-to-face 
interview at two weeks. The Johns Hopkins Institutions Institutional Review Board approved 
this study. 
Measures 
Baseline measures included demographics (e.g., age, race/ethnicity, household 
composition), reproductive and sexual history, and perceived social support. Follow-up visits 
collected data on the PID self-management behaviors of medication completion, clinical 
follow-up visit attendance, partner notification, and temporary abstinence from sexual 
intercourse, as well as received social support and coping strategies used during the treatment 
period. To measure received social support, participants were asked to indicate the types of 
support their parents/guardians (parents) provided after their diagnosis (i.e., provided 
comfort, offered advice, reminded them to take their medication, took them to the clinical 
follow-up visit, or encouraged them to talk to their partners). 
Perceived social support. Perceived social support, defined as the belief that others 
are available and desire to help if the individual needs it, was operationalized as the Social 
Provisions Scale (SPS). The SPS examines the degree to which an individual’s social 
relationships provide various dimensions of social support. The SPS contains 24 items, with 
four items to measure each of the following six social provision dimensions: attachment, 
social integration, reassurance of worth, reliable alliance, guidance, and opportunity for 
nurturance (Cutrona & Russell, 1987). Utilizing a scale ranging from 1 (“strongly disagree”) 
to 4 (“strongly agree”), respondents indicate the extent to which each item statement 
describes their current relationships with other people. SPS scores are determined by 




Higher scores indicate greater levels of perceived social support. Possible scores range from 
4 to 16 for each SPS subscale, and 24 to 96 for the overall SPS total. Internal consistency 
reliability of the total SPS score is excellent (Cronbach’s α = 0.915), with alpha coefficients 
on the individual scales ranging from 0.653 to 0.760 (Cutrona & Russell, 1987). In this study 
sample, Cronbach’s alpha for the total SPS was 0.89, and ranged from 0.52 to 0.78 for SPS 
subscales. 
Coping strategies. The Brief COPE, a 28-item instrument that measures several 
ways in which people respond to stress (Carver, 1997), was used to measure coping 
strategies. The 14 scales of the Brief COPE measure the following coping strategies: self-
distraction, active coping, denial, substance use, use of emotional support, use of 
instrumental support, behavioral disengagement, venting, positive reframing, planning, 
humor, acceptance, religion, and self-blame. Active coping, use of instrumental support, and 
planning are problem-focused coping strategies, while the remaining coping strategies are 
emotion-focused (Carver et al., 1989). The frequency of use for each coping strategy item is 
measured on a 4-point scale, ranging from 1 (“I haven’t been doing this at all”) to 4 (“I’ve 
been doing this a lot”). Brief COPE scores are determined by calculating the mean for each 
scale, with a possible score range of 1 to 4. A higher score indicates a more frequent use of 
the coping response. Internal consistency reliability of the Brief COPE scales ranges from 
0.50 to 0.90 (Carver, 1997). Cronbach’s alpha in this study sample ranged from 0.54 to 0.93, 
except acceptance (0.27) and self-blame (0.49). 
Data Analysis  
Descriptive statistics were calculated to summarize the sociodemographic 




standard deviations of SPS scales and SPS total scores were calculated to measure perceived 
social support. Received social support was measured by calculating the frequencies of social 
support acts reported at follow-up. Coping strategies were summarized by calculating the 
means and standard deviations of Brief COPE scale scores and the relative frequencies of 
Brief COPE scale mean scores. Logistic regression analysis was utilized to examine 
relationships between PID self-management behaviors and perceived social support, received 
social support, and use of coping strategies. The PID self-management behavior outcomes of 
interest were medication completion, clinical follow-up visit attendance, partner notification, 
and sexual abstinence. We constructed multiple logistic regression models for each PID self-
management behavior outcome and social support or coping strategy variable, adjusting for 
age, STI history, health insurance coverage status, and group assignment. Selected covariates 
were consistent with previously published PID self-management research (Trent et al., 2010). 
Group assignment was included as a covariate to control for the variable’s potential to be a 
confounder; the parent study intervention aimed to improve adherence to the PID treatment 
recommendations analyzed in this study. Because clinical follow-up assessment was a 
principal component of the parent study intervention (i.e., all intervention group participants 
received a community-based clinical follow-up visit), clinical follow-up visit attendance was 
analyzed only for control group participants, and group assignment was not included as a 
covariate in clinical follow-up visit multiple logistic regression models. Social support and 
coping strategy variables with p-values < 0.10 in multiple logistic regression models were 
selected to create interaction terms to test the moderating effect of social support on the 
relationship between coping strategies and PID self-management behaviors. A significance 




95% confidence intervals (CIs) were reported. Data analysis was performed using Stata I/C, 
version 15 (StataCorp LP, College Station, TX). 
Results 
Demographics  
The sample for this study consisted of 90 participants who completed the baseline, 
two-week, and one-month TECH-N study protocol visits. The mean age was 19.2 years (SD 
= 2.9). Most participants were African American (94.4%), had health insurance (92.3%), and 
had a primary care provider (68.9%). Approximately 59% of the participants had a positive 
STI history, and 16.7% had at least one prior PID diagnosis. Approximately 37% of 
participants reported using any birth control at last intercourse, and 12% used dual protection 
(i.e., barrier and hormonal contraception) (Table 4.1). 
Social Support 
 The highest levels of perceived social support were within the social provision 
domains of guidance (mean = 12.3, SD = 2.4) and reliable alliance (mean = 12.1, SD = 2.7), 
and the lowest were reassurance of worth (mean = 11.4, SD = 2.0) and attachment (mean = 
11.7, SD = 2.2). Approximately 68% of participants told a parent about their PID diagnosis, 
and 88.5% of the young women who told a parent received support from the notified parent. 
Medication reminders were the most commonly reported support received from a parent 
(48.9%). One control group participant reported that a parent took her to her clinical follow-
up visit (Table 4.2). 
Coping Strategies 
 The most frequently used coping strategies were active coping and acceptance, with 




Observing the frequency of coping strategy use by percentages of corresponding subscale 
scores, 71% of participants used acceptance “a lot”, and 69% used active coping “a lot” 
(Table 4.3). The least frequently used coping strategies were substance use (mean = 1.2, SD 
= 0.68), behavioral disengagement (mean = 1.2, SD = 0.69) and humor (mean = 1.3, SD = 
0.76). Most participants indicated that they had not used those coping strategies at all (i.e., 
subscale score = 1): substance use (88%), behavioral disengagement (87%), humor (84%).  
PID Self-Management 
At the two-week follow-up visit, 41.1% of participants reported that they had finished 
taking all the antibiotic pills. Approximately 14% of control group participants attended the 
clinical follow-up visit. While 89% of participants reported that they notified their sexual 
partners, 46% reported that their partners had received STI treatment. Twenty-three percent 
of participants reported that their partners had not been treated for STIs, and 29% did not 
know if their partners had been treated. Approximately 81% of participants reported that they 
abstained from sexual intercourse during the two-week treatment period (Figure 4.2). Two 
participants declined to answer questions about partner notification, partner treatment, and 
sexual abstinence at two-week follow-up.  
Multiple logistic regression models indicated few statistically significant relationships 
between PID self-management and coping strategies or social support. Medication 
completion was not associated with any coping strategies examined in this study. Although 
not statistically significant, there was a trend such that participants who used active coping 
more frequently were less likely to complete their medications (adjusted odds ratio (AOR) = 
0.54; 95% CI: 0.28-1.05; p = 0.07). Opportunity for nurturance was the only social provision 




0.05); young women with greater perceptions of nurturance (responsibility for others) had 
26% higher odds of medication completion. While there were no coping strategies associated 
with clinical follow-up visit attendance, participants who reported an increased perception of 
nurturance had 2.43 times higher odds of attending the follow-up visit (95% CI: 1.19-4.93; p 
= 0.01). Regarding partner notification, there were no statistically significant associations 
with coping strategies or social support. There were trends such that participants who used 
planning as a coping strategy (AOR = 1.90; 95% CI: 0.94-3.83; p = 0.07) and perceived 
higher levels of social integration (AOR = 1.54; 95% CI: 0.94-2.51; p = 0.09) and 
opportunities for nurturance (AOR = 1.58; 95% CI: 0.95-2.63; p = 0.08) were more likely to 
notify their partners. Sexual abstinence was not associated with any of the coping strategies 
or social provisions assessed. None of the supportive care received from parents/guardians 
were significantly associated with PID self-management among the young women. 
Discussion 
This study examined social support and coping strategies in relation to self-
management among young women diagnosed with and treated for PID. Problem-focused 
coping strategies—active coping and planning—comprised two of the three most frequently 
used coping strategies in this sample. Active coping was a frequently used coping strategy, 
which was consistent with behavioral disengagement being one of the least frequently used 
strategies. Participants did not turn to substance use, limit their efforts to handle the situation, 
or make fun of their PID diagnosis and treatment to deal with their situation. However, none 
of the coping strategies examined were significantly associated with the PID self-
management behaviors assessed in this sample. That is, use of coping strategies did not 




management behaviors of medication completion, clinical follow-up visit attendance, partner 
notification for treatment, and temporary sexual abstinence.  
Although prior studies did not measure coping with PID, some studies examined 
coping with STIs related to PID. Schwartz et al. (2008) used selected Brief COPE subscales 
to investigate the coping responses elicited by a diagnosis of chlamydia and/or gonorrhea in a 
sample of urban, ethnic minority adults. Problem-focused coping comprised the most 
commonly used strategies, and behavioral disengagement was the least commonly used 
coping strategy. As with this study, Schwartz et al. (2008) found no associations between 
coping strategies and partner notification. Rosenthal et al. (1995) used the KIDCOPE, a 10-
item standardized instrument developed to assess coping with various kinds of problems, in a 
study of adolescent girls (mean age = 16.8 years) with a history of at least one STI episode. 
Results indicated that wishful thinking was the most frequently used coping strategy (95%), 
followed by problem solving (81%) and emotional regulation (79%). Baker et al. (2001) 
utilized the KIDCOPE to evaluate whether adolescent girls use similar coping strategies in 
response to STI acquisition and to an interpersonal stressor, such as a conflict with a friend. 
Wishful thinking (96%), blaming others (78%), and internal emotional regulation (72%) 
were the most frequently used coping strategies in response to STI acquisition. Self-blame 
was used more often in response to STI acquisition than in response to the interpersonal 
stressor (40% vs. 26%), while problem solving was used less often (43% vs. 58%). The use 
of different coping instruments and measurement approaches precludes comparisons of 
coping with STIs by young women in previous studies and coping with PID by young 




Consistent with prior research, findings from this study identified opportunity for 
nurturance as a baseline social provision associated with post-diagnosis behavior among 
young women with PID. Munõz Buchanan et al. (2016) observed that opportunity for 
nurturance was negatively associated with parental notification. Young women with an 
increased sense of responsibility for the well-being of others were less likely to notify a 
parent of their PID diagnosis. In the current study, opportunity for nurturance was positively 
associated with medication completion and clinical follow-up visit attendance; young women 
with an increased sense that others rely on them for their well-being were more likely to 
complete their medications and attend the clinical follow-up visit. The emergence of 
opportunity for nurturance in this study suggested that feeling responsible for others is 
connected to a sense of responsibility for meeting other obligations—such as medication 
adherence and clinical appointment attendance—among young women diagnosed with and 
treated for PID. Reassurance and reliable alliance were positively associated with parental 
notification in the Munõz Buchanan et al. (2016) study, but no statistically significant 
relationships between those social provisions and PID self-management were found in the 
current study sample.  
Although young women with higher opportunity for nurturance scores had higher 
odds of medication adherence or clinical follow-up visit attendance, overall adherence to 
those PID treatment recommendations was low. Less than 15% of the control group returned 
for follow-up care within 72 hours, and less than half of all study participants completed the 
antibiotic therapy as prescribed. While previous PID self-management research has identified 
unpleasant side effects (e.g., nausea and vomiting) as a reason for medication non-adherence 




51 participants who did not complete the treatment regimen—reported that they experienced 
side effects. Partner notification and temporary abstinence rates were high within this study 
sample, and there were no coping strategies or types of social support associated with 
increased or decreased adherence to those PID treatment recommendations.  
The proportion of participants in the current study who informed a parent of their PID 
diagnosis (68%) mirrored the 65% proportion noted by Munõz Buchanan et al. (2016). 
However, fewer participants in the current study reported parental engagement in PID care 
(60% vs. 74%). Although most of our participants told a parent about their PID diagnosis and 
subsequently received support from a parent, that support was not associated with adherence 
to PID treatment recommendations. While this study focused on support received from 
parents, it must be acknowledged that there are other potential sources of social support (e.g., 
friends, other relatives) that were not examined in this study.  
The current study lays the groundwork for future research aimed at better 
understanding the coping strategies and social support that affect adherence to PID treatment 
recommendations among young women. However, several limitations must be considered. 
All collected data were self-reported by study participants, which introduced the potential for 
recall bias. Recall bias may have been unintentional due to poor or incomplete memory 
recall, or intentional due to perceived social desirability. However, data were collected via 
ACASI, which has been shown to decrease the incomplete or inaccurate reporting of 
sensitive behaviors such as sexual activity (Ghanem, Hutton, Zenilman, Zimba, & Erbelding, 
2005; Rogers et al., 2005). In addition, structured face-to-face interviews were conducted by 




The sample for the current study was recruited from one urban academic health 
center; therefore, the psychosocial characteristics and self-management behaviors may not be 
generalizable to young women diagnosed with and treated for PID in other geographic 
locations or at other types of health care organizations. With a proportion over 90% 
Black/African American, our sample lacked racial/ethnic diversity. Acknowledging that the 
lifetime self-reported history of PID diagnosis among non-Hispanic Black and non-Hispanic 
White sexually experienced women of reproductive age (18-44 years) in the United States 
with a previous STI diagnosis is nearly equal (10.0 % vs. 10.3%), it is important to include 
all groups affected by the disease in health promotion research (Kreisel, Torrone, Bernstein, 
Hong, & Gorwitz, 2017). The relatively small sample size may not have had sufficient power 
for logistic regression analyses to detect some meaningful differences as statistically 
significant. Additional research with larger sample sizes is needed to determine whether 
coping strategies, perceived social support, task-specific support such as medication 
reminders, and emotional support such as comfort are associated with PID self-management. 
Despite these limitations, study strengths included conducting the study among young 
women residing in a community with high STI rates (Maryland Department of Health, 2017) 
and assessing coping strategies specific to receiving the PID diagnosis and treatment, rather 
than global coping, dispositional coping, or coping with a hypothetical situation. 
Additionally, coping strategies were assessed two weeks after PID diagnosis, thus reducing 
the risk of recall bias. While previous studies concerning adherence to PID treatment 
recommendations were limited to correlations with demographic characteristics such as age, 
the current study investigated relationships between PID treatment adherence and 





PID during adolescence and young adulthood increases vulnerability to long-term 
adverse reproductive health outcomes and negative health-related quality of life. It is 
important for interdisciplinary health care providers to understand the roles of psychosocial 
factors such as coping and social support in PID self-management to develop and implement 
effective strategies to improve health outcomes among young women with PID. This 
observational study investigated how social support and coping strategies relate to PID self-
management among young women. Previous analyses of PID self-management have been 
limited to correlations with sociodemographic characteristics such as age, with no 
examination of the psychosocial barriers to and facilitators of PID self-management. 
Although additional research is needed to determine relationships with PID self-management 
behaviors, the results of this study offer an initial suggestion as to which coping strategies 
































Age, years (mean, SD) 19.2 (2.9) 
Race/Ethnicity  n (%) 
African American/Black 85 (94.4) 
White 3 (3.3) 
Latina/Hispanic 2 (2.2) 
Recruitment site  n (%) 
Pediatric emergency department 48 (53.3) 
Adult emergency department 30 (33.3) 
Pediatrics and adolescent medicine clinic 12 (13.3) 
Group assignment n (%) 
Intervention 48 (53.3) 
Control 42 (46.7) 
Has a primary care provider 62 (68.9) 
Health insurance  n (%) 
Medicaid  77 (85.6) 
Private 6 (6.7) 
None 7 (7.8) 
Lives with family member(s) 77 (85.6) 
Sexual history mean (SD) 
Lifetime male partners  5.7 (4.7) 
Male sex partners in last 3 months 1.5 (0.9) 
History of STI 53 (58.9) 









































a: Control group only 
 
Perceived social support - Social Provisions Scale Mean (SD) Range 
Guidance 12.3 (2.4) 6-16 
Reassurance of worth 11.4 (2.0) 8-16 
Social integration 11.9 (1.9) 8-16 
Attachment 11.7 (2.2) 7-16 
Opportunity for nurturance 11.8 (2.0) 8-16 
Reliable alliance 12.1 (2.7) 4-16 
Social Provisions Scale total 71.3 (10.1) 52-96 
Received social support n (%)  
Told parent/guardian about PID diagnosis 61 (67.8)  
Received supportive care from parent/guardian 54 (60.0)  
Support received from parent/guardian n (%)  
Reminders to take medication  44 (48.9)  
Comfort 29 (32.2)  
Advice 26 (28.9)  
Encouragement to talk to partner 9 (10.0)  




Table 4.3 Coping strategy use frequency (n = 90) 
 
 % of Participants 
Coping Strategy Not at all A little bit A medium amount  A lot  
Problem-Focused     
Active coping  1 8 22 69 
Planning 16 12 28 44 
Use of instrumental support 26 20 24 30 
Emotion-Focused     
Acceptance 2 6 21 71 
Use of emotional support  24 12 13 51 
Self-distraction 21 16 30 33 
Positive reframing 33 19 19 29 
Religion 39 14 20 27 
Self-blame 38 23 29 10 
Denial 59 12 10 19 
Venting 52 20 17 11 
Humor* 84 4 7 4 
Behavioral disengagement 87 8 1 4 
Substance use 88 2 7 3 
Coping strategy scores: “Not at all” = 1; “A little bit” = 1.5-2; “A medium amount” = 2.5-3; “A lot” = 3.5-4 





Figure 4.1 Coping Strategies Used by Young Women Diagnosed with PID (n = 90)a 
 
Frequency of Use legend: 1 = I haven’t been doing this at all; 2 = I’ve been doing this a little bit; 3 = I’ve been 
doing this a medium amount; 4 = I’ve been doing this a lot 
a: Error bar represents one standard deviation 
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Figure 4.2 PID Self-Management Reported at 2-Week Follow-Up (n = 90) 
 
*: 2 participants did not answer 
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CHAPTER FOUR ADDENDUM: INSTRUMENT INTERNAL CONSISTENCY 
RELIABILITY 
Table 4.4 Social Provisions Scale Reliabilities 
Provision α (Current Study)  α (Russell & Cutrona, 1987a) 
Attachment 0.53 0.747 
Social Integration 0.63 0.673 
Reassurance of Worth 0.52 0.665 
Reliable Alliance 0.78 0.653 
Guidance 0.70 0.76 
Opportunity for Nurturance 0.57 0.655 
Total Social Provision Score 0.89 0.915 
a: Reliability values from the original study are provided for reference. 
Table 4.5 Brief COPE Reliabilities 
Coping Strategy α (Current Study)  α (Carver, 1997a) 
Self-distraction 0.65 0.71 
Active coping 0.54 0.68 
Denial 0.85 0.54 
Substance use 0.93 0.90 
Use of emotional support 0.84 0.71 
Use of instrumental support 0.69 0.64 
Behavioral disengagement N/Ab 0.65 
Venting 0.63 0.50 
Positive reframing 0.75 0.64 
Planning 0.56 0.73 
Humor 0.89 0.73 
Acceptance 0.27 0.57 
Religion 0.75 0.82 
Self-blame 0.49 0.69 
a: Reliability values from the original study are provided for reference. 
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Pelvic inflammatory disease (PID) during adolescence and young adulthood increases 
vulnerability to long-term adverse reproductive health outcomes and negative health-related 
quality of life. Nonadherence to PID treatment recommendations increases risk for 
subsequent sexually transmitted infections (STIs) and recurrent PID. Limited improvements 
in outpatient PID treatment adherence generated by interventions focused on clinician 
practices, patient education, and behavioral modeling suggest that psychosocial factors, such 
as coping, may influence self-management behaviors. This convergent mixed methods study 
of 18 urban young women diagnosed with PID used descriptive statistics to analyze 
perceived social support, coping strategies, social support received from parents, and PID 
self-management behaviors (medication adherence, clinical follow-up visit attendance, 
partner notification, and sexual abstinence). Semi-structured interviews were conducted to 
explore the experiences of young women diagnosed with and treated for PID. Quantitative 
and qualitative data were integrated at the data interpretation level. Acceptance and active 
coping were the most frequently used coping strategies. Upon learning about their diagnosis, 
young women were motivated to ameliorate PID, often with support from family and friends. 
PID self-management was incorporated into their daily routine. Survey results indicated that 
most young women notified their partners and abstained from sex during the treatment 
period, but adherence to the medication completion and clinical follow-up visit attendance 
recommendations was relatively low. However, the interviews revealed that some young 
women completed their medication and/or returned for follow-up after the recommended 
period. Assessing young women’s perceptions of PID and coping resources can inform best 











Each year, approximately 800,000 cases of pelvic inflammatory disease (PID) are 
diagnosed in the United States (Greydanus & Dodich, 2015). PID comprises a spectrum of 
inflammatory disorders of the female upper genital tract that arise from genital infections 
commonly attributed to sexually transmitted organisms, such as Neisseria gonorrhoeae (GC) 
and Chlamydia trachomatis (CT) (Centers for Disease Control and Prevention, 2015; 
Handsfield, 2011). PID poses a long-term threat to reproductive health, with complications 
that include chronic pelvic pain, ectopic pregnancy, and tubal infertility (Brunham, Gottlieb, 
& Paavonen, 2015; Greydanus & Dodich, 2015). The current standard of care for treatment 
of mild to moderate PID as recommended by the Centers for Disease Control and Prevention 
(CDC) includes a 14-day course of outpatient oral antibiotic therapy and pain management, 
partner notification for treatment, sexual abstinence until patient and partner are treated, and 
a follow-up evaluation within 72 hours of diagnosis to assess for clinical improvement 
(Centers for Disease Control and Prevention, 2015).  
Large clinical trials such as the Pelvic Inflammatory Disease Evaluation and Clinical 
Health (PEACH) study demonstrated that inpatient delivery of antibiotic therapy was not 
superior to outpatient antibiotic treatment for mild to moderate PID, which prompted the 
CDC to recommend outpatient treatment for mild to moderate PID. However, self-
management among young women with respect to adherence to the CDC-recommended 
outpatient treatment regimen is suboptimal, thereby increasing the risk for adverse 
reproductive health outcomes (Trent, 2013b). Medication adherence measured by electronic 
event monitoring in a subgroup of PEACH study participants demonstrated that women took 




& Ness, 2004; Trent, Judy, Ellen, & Walker, 2006). Approximately 29% of all PEACH study 
participants reported that their partners received STI treatment after their PID diagnosis, and 
approximately 15% reported failure to abstain from sexual intercourse during the PID 
treatment period (Trent et al., 2011). A retrospective chart review of adolescents diagnosed 
with PID at an urban teen clinic indicated that 23% of patients did not adhere to the 
medication regimen and sexual abstinence recommendations. Girls with a history of one PID 
episode were 1.44 times more likely than girls with recurrent PID to report adherence to 
treatment recommendations, suggesting that adolescents with recurrent PID were less 
adherent to treatment and self-management recommendations than their single-episode peers 
(Kelly, Ireland, & Aughey, 2004). Compared to their older counterparts, adolescents and 
young women diagnosed with PID are at increased risk for subsequent STIs and PID, and 
adverse reproductive health outcomes. At 30-day follow-up, 20% of adolescent PEACH 
study participants tested positive for an STI, compared to 5.2% of adult participants (Trent et 
al., 2011). Although the CDC (2015) identifies adolescents as a special population in the 
STD Treatment Guidelines, there are no special considerations for PID treatment among 
adolescents. Analyses of PEACH trial data led to the conclusion that inpatient treatment for 
mild to moderate PID would not be cost-effective for patients of any age. However, the 
PEACH trial had low representation among patients in early and middle adolescence: The 
mean age of participants younger than 19 years was 17.8 (SD = 1) years, which suggests that 
PEACH trial findings related to the effectiveness of outpatient treatment and self-
management may not be applicable to younger adolescents (Trent, 2013a).  
While the proportion of adolescent emergency department (ED) and clinic patients 




quality improvement intervention for the outpatient management of PID, 57% of patients did 
not follow up for care within 72 hours, and almost 40% of patients had not completed taking 
their medications at two weeks post-diagnosis. In structured follow-up telephone interviews, 
47% of patients did not identify what prevented them from following up for care, and 20% 
could not provide a reason for their failure to complete the prescribed medication regimen 
(Trent et al., 2006). In a randomized controlled trial of a brief video behavioral intervention 
for adolescents with mild to moderate PID, only 24% of all patients returned for a 72-hour 
follow-up clinical visit, and almost one-third of all participants did not complete their 
medications, with no statistically significant differences between the intervention and control 
groups (Trent, Chung, Burke, Walker, & Ellen, 2010). The limited improvements in 
outpatient treatment adherence generated by clinical quality improvement and behavioral 
interventions suggest that factors beyond clinician practices, patient education, and 
behavioral modeling influence PID self-management. Psychosocial factors—particularly 
coping strategies and social support—may influence self-management behaviors among 
young women diagnosed with PID, and therefore warrant exploration.  
This study aimed to explore the self-management experiences of urban adolescents 
and young adult women diagnosed with PID and examine the coping strategies utilized 
during the PID treatment period. The Transactional Model of Stress and Coping (TMSC), a 
framework for evaluating processes of coping with stressful events, was used to guide this 
study. Developed by Lazarus and Cohen, the TMSC posits that stressful experiences are 
construed as person-environment transactions, in which the impact of an external stressor, or 
demand, is mediated by the perceived significance of the stressor (primary appraisal) and the 




strategies mediate the emotional and functional effects of primary and secondary appraisals. 
Outcomes of the coping process are a person’s adaptation to a stressor, after appraising the 
situation and resources and being influenced by coping efforts (Glanz, Rimer, & Viswanath, 
2008). The coping outcomes of interest for the current study include the following PID self-
management behaviors: medication adherence, clinical follow-up visit attendance, partner 
notification, and sexual abstinence during the treatment period. 
Methods 
This study is an analysis of a subsample of participants in the Technology-Enhanced 
Community Health Nursing (TECH-N) study. As described in previously published research 
(Butz et al., 2016; Trent et al., 2016), TECH-N was a randomized controlled trial to evaluate 
an intervention consisting of daily medication reminders via text messaging and a follow-up 
clinical visit by a community health nurse (CHN) to improve clinical outcomes among young 
women diagnosed with PID. Study participants were recruited from the pediatric and adult 
EDs and a general pediatrics and adolescent medicine clinic of an academic health center in 
Baltimore, Maryland and enrolled in the study on the same day they were diagnosed with 
PID. This analysis includes participants who enrolled in the TECH-N study between June 
2015 and December 2016; this period commenced with the addition of an instrument to 
measure coping to the TECH-N protocol and concluded with the scheduled completion of 
TECH-N study enrollment. The sample for this study consisted of young women 13 to 25 
years of age who received standard of care treatment for mild to moderate PID, selected from 
the cohort of TECH-N control group participants who completed the 90-day protocol visit. 
Purposive sampling of control group participants supported the exploration of young 




TECH-N intervention. Quantitative data were collected via audio computer-assisted self-
interview (ACASI) at baseline and one month, and via structured face-to-face interview at 
two weeks. Qualitative data were collected via one-time, in-person, semi-structured 
interviews. The study was approved by the Johns Hopkins Institutions institutional review 
board. 
Measures 
Baseline measures included demographics (e.g., age, race/ethnicity, household 
composition), reproductive and sexual history, and perceived social support. During follow-
up visits, data were collected on the PID self-management behaviors of medication 
completion, clinical follow-up visit attendance, partner notification, and temporary 
abstinence from sexual intercourse, as well as received social support and coping strategies 
used during the treatment period. To measure received social support, participants were 
asked to indicate the types of support their parents/guardians provided after their diagnosis 
(i.e., provided comfort, offered advice, reminded them to take their medication, took them to 
the clinical follow-up visit, or encouraged them to talk to their partners). 
Perceived social support. Perceived social support, defined as the belief that others 
are available and desire to help if the individual needs aid, was operationalized as the Social 
Provisions Scale (SPS). The SPS examines the degree to which an individual’s social 
relationships provide various dimensions of social support. The SPS contains 24 items, with 
four items to measure each of the following six social provision dimensions: attachment, 
social integration, reassurance of worth, reliable alliance, guidance, and opportunity for 
nurturance (Cutrona & Russell, 1987). Using a scale from 1 (“strongly disagree”) to 4 




their current relationships with other people. SPS scores are determined by calculating the 
sum totals for each dimension’s subscale and the total over all subscales. Higher scores 
indicate greater levels of perceived social support. Possible scores range from 4 to 16 for 
each SPS subscale, and 24 to 96 for the overall SPS total. Internal consistency reliability of 
the total SPS score is excellent (Cronbach’s α = 0.915), with alpha coefficients on the 
individual scales ranging from 0.653 to 0.760 (Cutrona & Russell, 1987).  
Coping strategies. The Brief COPE, a 28-item instrument that measures several 
ways in which people respond to stress (Carver, 1997), was used to measure coping 
strategies. The 14 scales of the Brief COPE measure the following coping strategies: self-
distraction, active coping, denial, substance use, use of emotional support, use of 
instrumental support, behavioral disengagement, venting, positive reframing, planning, 
humor, acceptance, religion, and self-blame. Active coping, use of instrumental support, and 
planning are problem-focused coping strategies, while the remaining coping strategies are 
emotion-focused (Carver, Scheier, & Weintraub, 1989). The frequency of use for each 
coping strategy item is measured on a 4-point scale, from 1 (“I haven’t been doing this at 
all”) to 4 (“I’ve been doing this a lot”). Brief COPE scores are determined by calculating the 
mean for each scale. Higher scores indicate more frequent use of the coping response. 
Internal consistency reliability of the Brief COPE scales ranges from 0.50 to 0.90 (Carver, 
1997).  
Qualitative data. Utilizing a qualitative descriptive approach (Sandelowski, 2000), 
the semi-structured interview guide included open-ended questions to explore the 
experiences of young women diagnosed with and treated for PID. Interview questions 




the PID diagnosis, coping with the PID diagnosis, social support received during the PID 
treatment period, and PID self-management. After providing informed consent, participants 
completed a brief demographic and health history questionnaire, which was verbally 
administered by the interviewer. The semi-structured interview was conducted immediately 
after completion of the questionnaire. Participants received $40.00 remuneration at the 
completion of the interview. Interviews were audio recorded and transcribed verbatim. 
Written notes were recorded during and after the interviews to capture additional details. 
Transcripts, audio recordings, and notes were reviewed after each interview to determine data 
saturation and to add reflexivity (i.e., interview guide revisions) prior to the next interview.  
Data Analysis  
Quantitative data. Descriptive statistics were calculated to summarize the 
sociodemographic characteristics and sexual/reproductive health history of study 
participants. Means and standard deviations of SPS scales and SPS total scores were 
calculated to measure perceived social support. Received social support was measured by 
calculating the frequencies of social support activities reported at follow-up. Coping 
strategies were summarized by calculating the means, standard deviations, and frequencies of 
Brief COPE scale scores. Stata I/C, version 15 statistical analysis software (StataCorp LP, 
College Station, TX) was used to analyze data. 
Qualitative data. Data were analyzed using a qualitative content analysis procedure 
(Hsieh & Shannon, 2005). Transcripts and field notes were analyzed after each interview to 
determine data saturation and to add reflexivity prior to the next interview. Verified 
transcripts were imported into a qualitative research software program, f4analyse, for data 




and grouped by shared characteristics. For this study, codes were derived from TMSC 
concepts and PID self-management behaviors. Groups of repeating codes or ideas were 
aggregated into categories. Field notes recorded during the interviews were incorporated into 
the analyses. Interviews were analyzed throughout the data collection process; codes, 
categories, and themes that appeared not to be fully developed in initial interviews were 
made richer through modifications to the interview guide. The first author read all transcripts 
and created a codebook for all relevant text data. A second coder independently coded data 
by applying the codebook to three transcripts, and the finalized codebook was confirmed by 
discussion and consensus between the coders. The first author and second coder 
independently coded three additional transcripts using the finalized codebook and discussed 
their analyses, for a cumulative 33% of transcripts analyzed by a second coder. The first 
author analyzed all interview transcripts. 
 Integration of quantitative and qualitative data. Data were organized and 
evaluated for patterns in participant descriptions of PID self-management behaviors by Brief 
COPE scores (coping) and SPS scores (social support). Quantitative and qualitative results 
were integrated in narrative by using quotes from the interviews to illustrate the PID self-
management behaviors of the study participants and related coping strategies.  
Results 
Participants  
The study sample consisted of 18 young women who completed TECH-N study 
protocol visits and an in-depth, in-person semi-structured qualitative interview. Two-week 
data were missing for two participants. Mean age at PID diagnosis was 18.2 years (SD = 2.1), 




were interviewed approximately 9 months (mean = 9.4, SD = 5.4) after receiving the PID 
diagnosis. The amount of time that passed between PID diagnosis and interview participation 
ranged from 3 to 21 months. Most participants were African American (89%), had health 
insurance (94%), and had a primary care provider (PCP) (78%). At baseline, approximately 
78% of the participants had a positive STI history, and 39% had at least one prior PID 
diagnosis. Approximately 44% of participants reported using any birth control at last sexual 
intercourse prior to PID diagnosis, and 11% used dual protection (i.e., barrier and hormonal 
contraception) (Table 5.1). 
Primary and Secondary Appraisals of PID 
Primary appraisal. Few participants were familiar with PID prior to receiving their 
diagnosis, and the young women who had heard of PID had limited knowledge of the 
disease. Finding out that the abdominal pain that prompted them to seek medical attention 
was caused by something called “pelvic inflammatory disease” evoked confusion and fear. 
Some young women were afraid because they thought PID was a permanent illness, as 
expressed by 18-year-old Rose (pseudonyms used for study participants): “I thought it was 
something that wouldn't go away. I was scared, I didn't know what to do.” Initial confusion 
and fear gave way to shock, sadness, and anger when the young women found out that PID 
came from having an STI.  
Secondary appraisal. Secondary appraisal includes the perceived ability to change 
the situation and expectations about the effectiveness of one’s coping resources (Glanz et al., 




change the situation (i.e., “get rid of” PID): “I felt relieved because then I was like ‘Okay, at 
least I know it's something I can get rid of.’" (Rose, 18 years old) 
Coping resources include social support, and the highest levels of perceived social 
support for the young women were within the social provision domains of reliable alliance 
(mean = 13.1, SD = 2.3) and guidance (mean = 12.9, SD = 1.9). The lowest were reassurance 
of worth (mean = 12.0, SD = 1.4) and attachment (mean = 12.1, SD = 1.9) (Table 5.2). 
Explaining why she told her mother and aunt about her PID diagnosis, 17-year-old Violet 
believed it was important for them to know about it, and she anticipated receiving much-
needed support from them: “I felt like it was a big deal. I just felt like they both should have 
known and I'm really horrible at taking medication, so I needed somebody to remind me to 
take my medication.” 
Coping 
The most frequently used coping strategies were acceptance and active coping: 94% 
of participants used acceptance “a lot”, and 69% of participants used active coping “a lot.” 
The least frequently used coping strategies were behavioral disengagement, substance use, 
and humor. Most participants indicated that they had not used those coping strategies at all 
(i.e., subscale score = 1): behavioral disengagement (94%), substance use (88%), humor 
(88%) (Table 5.3). After diagnosis, participants aimed their attention at active steps to 
ameliorate PID. Planning and active coping primarily focused on taking medication: “I 
wanted to get rid of it. I wanted to get rid of it, so I just was like, I had set up a schedule of 
the time to take the medicine.” (Lily, 18 years old) 
Most participants (72%) told a parent about their PID diagnosis and subsequently 




advice (33%), and/or encouragement to talk to partners (17%). Approximately 70% of 
participants reported using instrumental support (e.g., advice, information) or emotional 
support (e.g., reassurance) a medium amount or a lot to cope with having PID. Young 
women revealed in the interviews that they also received support from other family members, 
friends, and partners, as 18-year-old Daisy described support from her best friend: 
 She called me every morning "Hey you take your medicine?" And at night, "Hey you 
took your medicine?" Sometimes I just felt like I didn't want to get out the bed so [she 
would say] "I’mma come over. You don't have to get out the bed, we can watch 
movies."  
Although study participants disclosed their PID diagnosis to trusted persons and 
subsequently received support, many of the young women concealed the physical and 
emotional burdens of PID that they experienced: 
I just acted like a regular, normal person. Like if nothing ever happened. But I knew 
deep down inside. Like my inside was hurting. Like I was upset. I was crushed on the 
inside, but the outside you couldn't, you wouldn't be able to tell. I was a regular 
happy person. Keep smiling. Nobody knew I was going through anything but me. 
(Ivy, 16 years old) 
PID Self-Management  
Study participants described experiences with pain, the emotional stress of PID and 
STI diagnoses, and distasteful medicine, but those difficulties did not deter the young women 
from engaging in PID self-management. They were self-motivated to get rid of PID. 
Participants described incorporating PID self-management into their lives as part of their 




There were no apparent patterns in PID self-management behaviors according to SPS and 
Brief COPE scores. 
Medication adherence. At two-week follow-up, 56% of participants reported that 
they had completed the antibiotic therapy. Non-adherence could not be attributed to lack of 
knowledge, as 89% correctly recalled the number of days they were advised to take the 
medications. The discrepancy between reported medication adherence and PID treatment 
knowledge may be attributed to young women inadvertently extending the length of time for 
medication completion. While all participants disclosed during their interview that they took 
all pills that were dispensed to them, some of them described taking longer than the 
recommended 14 days to finish taking the medicine. Delayed or missed doses were largely 
unintentional, and the young women were concerned about the potential consequences of 
missing a dose:  
I went on vacation to West Virginia and I didn't bring my medicine with me. I stayed 
there for the weekend, so I was kind of freaking out when I realized I didn't bring my 
medicine with me. I couldn't do anything but when I got back, I asked if it was okay if 
I could double dose, but I didn't . . . She said don't double dose the medicine, so I just 
took my medicine for that day when I got back and then I just kept taking it as 
regular. I just had to take it for longer than what I would have to. (Violet, 17 years 
old) 
Remembering to take the medication on time was difficult for some young women, 
and they worried that missing a dose or taking a dose late would render the PID treatment 
ineffective. Lily (18 years old) expressed, “Yeah it's easy to forget. It's so easy to forget. So, 




Young women described using memory aids such as alarms, but they also relied on others to 
remind them to take their medicine. Quantitative data indicated medication reminders as the 
support most commonly received from a parent (50%), and qualitative data revealed that 
young women also received medication reminders from other relatives, friends, and 
boyfriends.  
Medication completion was the priority PID self-management behavior among the 
young women, who understood the importance of finishing an antibiotic regimen: 
I guess just the most important thing is just finishing your medicine, even if you feel 
better, because I think a lot of people ... they just think once they're feeling better they 
can just stop taking it. But you have to finish it all, for it all to work. (Holly, 19 years 
old) 
There was high expectancy attributed to medication adherence. Participants trusted that 
finishing the medicine dispensed to them would cure their PID: “As long as you take the 
medicine, you’re good.” (Iris, 18 years old) 
Clinical follow-up visit attendance. At the TECH-N two-week protocol visit, only 
three participants (17%) reported that they had attended a clinical follow-up visit within 72 
hours of PID diagnosis. One participant reported that a parent accompanied her to the follow-
up visit. One-month follow-up data suggest a disconnection between PID treatment 
recommendations and the patient education received and retained by young women: Four 
participants (22%) correctly recalled that they were advised to return for follow-up clinical 
evaluation within 72 hours after diagnosis. The most frequently selected response was two 
weeks after diagnosis (56%). Data indicated that young women sought clinical evaluation 




only three participants reported that they had not attended a clinical follow-up visit. Among 
participants who returned for follow-up more than 72 hours after PID diagnosis, some of 
them revealed that they already had an upcoming scheduled appointment with their PCP 
when they were diagnosed. They decided to wait for that appointment to inform their PCP of 
their PID diagnosis. Camellia (20 years old) explained that it made more sense to her to 
return for follow-up after she finished taking her medicine: 
Well, I really wanted to finish the pills first, and I didn't just want to run up there and 
still be there and not be able to know why, because I hadn't finished the medication so 
I'm just like, it would make more sense to me if I just wait until after the medication 
and that way they can check and make sure it's completely gone.  
Reasons for never returning for follow-up included the lack of an available appointment with 
the PCP and forgetting to schedule the appointment. 
Partner notification. Two weeks after PID diagnosis, 88% of participants reported 
that they notified their sexual partners of their PID diagnosis, and 63% of them reported that 
their partners had received STI treatment. By the time they were interviewed, 94% of 
participants had notified their partners, who were current and former boyfriends, casual 
partners, and a husband. Young women informed their partners about PID and the connection 
to STIs and advised them to seek medical attention (“You need to get checked”). Partner 
notification was accusatory for some participants (“You gave me something”), while others 
used a non-confrontational approach. No participants expressed fear related to notifying 
partners. The one participant who did not notify her partner was no longer in contact with 




relationship, her partner told her that he was routinely tested for STIs; therefore, she believed 
that he should have been tested and treated in the meantime:  
I haven't been talking to him for a minute, so I don't . . . I don't know exactly where he 
is at all. He don't have a social media or anything. His phone is off. I don't know, I 
haven't talked to him . . . But he claimed that he get check-ups every three months . . . 
It's been longer [than three months] since I talked to him. (Lily, 18 years old) 
Sexual abstinence. Approximately 81% of participants reported that they abstained 
from sexual intercourse during the two-week treatment period. Some young women disclosed 
that it was easy to adhere to the sexual abstinence recommendation because they were not 
sexually active around the time of PID diagnosis, and sex was not that important to them. 
Participants also described abstaining from sex because they were upset with their partners 
for betraying their trust and infecting them with an STI. They continued to abstain after the 
treatment period because they were afraid of contracting another STI and getting PID again. 
Trusting their partner was a concern: 
I was really scared to have sex after that honestly. Even though I knew he was clean, 
I think that was something an issue that we have with our relationship. I was scared 
he was going to go back out and cheat on me and get something again and just give it 
right back to me or something along those lines, so I was just kinda like . . . I really 
don't want to have sex with you right now. (Violet, 17 years old) 
Discussion 
This observational study explored self-management among young urban women 
diagnosed and treated for PID, within the context of coping. Problem-focused coping 




coping strategies. Self-management was driven by a personal desire to cure PID, and young 
women incorporated the tasks of PID self-management into their daily lives. Young women 
often received support from parents, friends, partners, and other trusted persons during the 
PID treatment period.  
Though no previously published research has measured coping with PID, a few 
studies have examined coping with STIs that may cause PID. Schwartz et al. (2008) selected 
Brief COPE subscales to investigate the coping responses elicited by a diagnosis of 
chlamydia and/or gonorrhea in a sample of urban, ethnic minority men and women. Problem-
focused coping (identified by Schwartz and colleagues as a distinct coping strategy) was the 
most commonly used strategy, and behavioral disengagement was the least commonly used 
coping strategy. Using the KIDCOPE, a 10-item standardized instrument developed to assess 
coping with various kinds of problems, Rosenthal et al. (1995) found that wishful thinking 
(95%) was the strategy most frequently used by adolescent girls to cope with an STI, 
followed by problem solving (81%) and emotional regulation (79%). Also using the 
KIDCOPE, Baker et al. (2001) found that adolescent girls most frequently used wishful 
thinking (96%), blaming others (78%), and internal emotional regulation (72%) in response 
to STI diagnosis. The use of different instruments that do not measure the same collection of 
coping strategies precludes direct comparisons of coping with STIs by young women in 
previous studies and coping with PID by young women in this study. 
Most participants told a parent about their PID diagnosis and subsequently received 
support from a parent. This is consistent with previous research, such as Munõz Buchanan et 
al. (2016) who found that 65% of young women informed a parent of their PID diagnosis and 




participants described receiving social support (e.g., medication reminders) that they directly 
attributed to their adherence to PID treatment recommendations. While previous research has 
focused on support received from parents, this study explored additional sources of social 
support, including friends, partners, and other relatives. Study participants revealed that 
young women who did not disclose their PID diagnosis to a parent confided in other trusted 
persons who supported them throughout the treatment period. Thus, PID diagnosis 
counseling should include an assessment of the young woman’s coping resources and 
diagnosis disclosure plans. Asking a young woman who she plans to tell about her PID 
diagnosis would reveal potential sources of emotional and/or instrumental support. Young 
women who are unable to identify trusted family members, friends, or other persons may 
need self-management support from nurses throughout the treatment period. Personalized 
PID self-management support could include outreach or extended communication in the form 
of periodic phone calls, text messages, or other electronic communication to check on the 
young women and provide encouragement. Having a system in place for clinicians to receive 
and respond to contact initiated by the young women would also be beneficial. 
Previous research has shown that a PID diagnosis can be a distressing experience for 
women, primarily due to worry about long-term reproductive health (Newton et al., 2014). 
Our findings suggest that the stress of the PID diagnosis does not prevent young women from 
engaging in PID self-management, because they are motivated by the belief that PID can be 
cured. PID treatment adherence varied by type of self-management behavior. While partner 
notification and temporary sexual abstinence rates were high, slightly more than half of all 
study participants had completed the antibiotic therapy as prescribed by two-week follow-up, 




management research has identified unpleasant effects such as nausea and vomiting as 
reasons for medication non-adherence (Dunbar-Jacob et al., 2004; Trent et al., 2006). 
Qualitative interviews revealed that participants in the current study experienced similar 
issues, but they employed strategies to manage them and complete the prescribed course of 
antibiotics. Medication completion sometimes took longer than 14 days because of missed 
doses. Most participants were assessed by a clinician within one month after diagnosis, but 
few had returned for follow-up evaluation within the recommended three days after initiation 
of antibiotic therapy.  
This study contributes to understanding the coping strategies that affect adherence to 
PID treatment recommendations among young women and lays the groundwork for future 
research. However, several limitations must be considered. All collected data were self-
reported by study participants, which introduced the potential for recall bias. Recall bias may 
have been unintentional due to poor or incomplete memory recall, or intentional due to 
perceived social desirability. However, some data were collected via ACASI, which has been 
shown to decrease the incomplete or inaccurate reporting of sensitive behaviors such as 
sexual activity (Ghanem, Hutton, Zenilman, Zimba, & Erbelding, 2005; Rogers et al., 2005). 
Further, study team members engaged in rapport-building to increase participants' comfort 
with sharing information during face-to-face quantitative and qualitative data collection. All 
participants were recruited from one urban academic health center; therefore, the 
psychosocial characteristics and self-management behaviors may not be generalizable to 
young women diagnosed with and treated for PID in other geographic locations or at other 
types of health care organizations. The sample was approximately 90% Black/African 




included the examination of PID self-management behaviors within the context of coping. 
Previous analyses of PID self-management have been limited to correlations with 
sociodemographic characteristics such as age, with no examination of the psychosocial 
barriers to and facilitators of PID self-management. The current study assessed coping 
strategies specific to PID diagnosis and treatment, rather than global coping, dispositional 
coping, or coping with a hypothetical situation. Coping strategy use was assessed 
approximately two weeks after PID diagnosis, which reduced the risk of recall loss. In-depth 
interviews elucidated the self-management behaviors of young women diagnosed with PID, 
providing context that is not accessible via quantitative data collection. Previous qualitative 
research on PID was limited to the experiences of women 18 years of age and older, but the 
current study explored the perspectives and experiences of adolescents as young as 14 years 
of age. 
Conclusion 
PID during adolescence and young adulthood increases vulnerability to long-term 
adverse reproductive health outcomes and negative health-related quality of life (Brunham, 
Gottlieb, & Paavonen, 2015; Greydanus & Dodich, 2015). It is important for interdisciplinary 
health care providers to understand the roles of coping and other psychosocial factors in PID 
self-management to develop and implement effective strategies to improve health outcomes 
among young women with PID. Self-management of PID is an interpersonal process, as it 
requires the adoption of protective sexual behaviors to prevent STI reinfection and may 
involve other persons for care and support. PID diagnosis counseling provides an important 
opportunity for clinicians to assess young women’s perceptions of PID and resources to 




self-management. The results of this study suggest that the use of problem-focused coping 
strategies and social support may facilitate PID self-management among young women. 
Clinicians and young women should work together to develop a PID self-management plan 

























 Mean SD Range 
Age (years) 18  2 14-23 
Lifetime male partners  5  4  
Male sex partners in last 3 months 1  1  
    
Race/Ethnicity n %  
African American/Black 16  89  
White 1  6  
Latina/Hispanic 1  6  
Recruitment site     
Pediatric emergency department 11  61  
Adult emergency department 4  22  
Pediatrics and adolescent medicine clinic 3  17  
Has a primary care provider 14  78  
Health insurance     
Medicaid  16  89  
Private 1  6  
None 1  6  
Lives with family member(s) 16 89  
History of STI 14  78  
























Social Provisions Scale Mean  SD Range 
Guidance 12.9  1.9 9-16 
Reassurance of worth 12.0  1.4 9-15 
Social integration 12.3  2.2 8-16 
Attachment 12.1  1.9 10-16 
Opportunity for nurturance 12.2  1.9 9-16 
Reliable alliance 13.1  2.3 10-16 




Table 5.3 Frequency of coping strategy use (n = 16*)  
 
 % Participants 
Coping Strategy Not at all A little bit A medium amount A lot  
Problem-Focused     
Active coping  6% 6% 19% 69% 
Planning 6% 25% 19% 50% 
Use of instrumental support 25% 6% 38% 31% 
Emotion-Focused     
Acceptance 0% 0% 6% 94% 
Self-distraction 25% 0% 19% 56% 
Use of emotional support 19% 13% 19% 50% 
Positive reframing  25% 25% 19% 31% 
Religion  44% 25% 13% 19% 
Self-blame 38% 19% 25% 19% 
Denial 75% 13% 6% 6% 
Venting  50% 25% 19% 6% 
Humor  88% 6% 0% 6% 
Behavioral disengagement 94% 6% 0% 0% 
Substance use  88% 6% 6% 0% 
Brief COPE score categories: “Not at all” (1); “A little bit” (1.5-2); “A medium amount” (2.5-3); “A lot” (3.5-4) 
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Partner notification is a critical component of the national recommendations for 
pelvic inflammatory disease (PID) treatment and secondary prevention of sexually 
transmitted infections (STIs). Diagnosis disclosure to persons beyond sexual partners may 
have implications for PID self-management among adolescents and young adult (AYA) 
women, who often rely on family and others for support. Little is known about persons 
selected by AYA for diagnosis disclosure, reasons for disclosure, and disclosure outcomes. 
The purpose of this study was to explore diagnosis disclosure among PID-affected AYA to 
better understand the context of disclosure and illness management.  
Methods  
In-depth semi-structured interviews were conducted with a purposive sample of 18 
AYA (13-25 years old) diagnosed with and treated for PID in the emergency department or a 
general pediatrics and adolescent medicine clinic within an academic health center in 
Baltimore, Maryland. All potential participants contacted were enrolled in the control arm of 
a randomized controlled trial to improve outcomes after PID diagnosis. Prior to the 
interview, participants completed a structured questionnaire to collect demographic, social, 
and sexual health history information. Interview queries included persons selected for 
diagnosis disclosure, disclosure content, rationale for disclosure or nondisclosure, and 
responses to disclosure. Interviews were audio-recorded, transcribed, and uploaded to 
f4analyse for analysis. Content analysis was used to interpret text data and identify categories 





At the time of the interview, the median age of participants was 19.5 years (range: 15-
23) and median time since PID diagnosis was 9 months (range: 3-21). The median age at PID 
diagnosis was 18 years (range: 14-23). Three themes related to PID diagnosis disclosure 
emerged from the interviews. The main theme was need-to-know; participants disclosed only 
to persons whom they believed should know about the diagnosis. Participants’ perceptions of 
an individual’s need to know also shaped the information they disclosed about the diagnosis. 
Adhering to clinicians’ recommendations, participants disclosed the diagnosis to their sexual 
partners with the intent to prevent STI reinfection and PID recurrence. Two additional 
themes that emerged were seeking support without judgment and protecting privacy. 
Participants portrayed most parents and select other family members and friends as persons 
whom they could rely on for nonjudgmental support. To explain nondisclosure, they often 
discussed a belief that few people could be trusted not to divulge their diagnosis to other 
people. Participants described responses to disclosure that were supportive (e.g., reassurance) 
and unsupportive (e.g., rejection). However, all participants received emotional and/or 
instrumental support from at least one person after diagnosis disclosure, and they highly 
valued that support.  
Conclusions 
PID diagnosis disclosure is influenced by AYA’s perceptions of an individual’s need 
to know about the diagnosis to promote PID self-management and/or provide support. AYAs 
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CHAPTER SIX: DISCUSSION 
Summary 
Although effective PID treatment and subsequent prevention of recurrent STIs and 
PID are important for fertility preservation and improving health-related quality of life 
(Brunham et al., 2015; Greydanus & Dodich, 2015), many young women diagnosed with 
PID do not fully adhere to the CDC treatment recommendations (A. M. Kelly et al., 2004; 
Trent et al., 2011). The limited improvements in outpatient treatment adherence generated by 
quality improvement and behavioral interventions in clinical settings suggest that factors 
beyond clinician practices, patient education, and behavioral modeling influence PID self-
management. Psychosocial factors—particularly coping strategies and social support—may 
influence self-management behaviors among young women diagnosed with PID, but to our 
knowledge, no studies have investigated the roles of coping and social support in PID 
treatment adherence among young women. The current study used a convergent mixed 
methods design approach to examine and explore the coping strategies, social support, and 
self-management behaviors of young women diagnosed with PID during the two-week 
treatment period. Problem-focused coping strategies, such as active coping, comprised the 
coping strategies most frequently used during the PID treatment period. However, none of 
the coping strategies examined were significantly associated with the PID self-management 
behaviors assessed in the study sample. Although young women with an increased sense of 
responsibility for others (i.e., a higher SPS opportunity for nurturance score) were more 
likely to complete their medications and attend the clinical follow-up visit, overall adherence 
to those PID treatment recommendations was low: Less than half of all study participants 




received standard of care PID treatment (i.e., TECH-N control group participants) returned 
for follow-up care within 72 hours. Qualitative findings revealed that upon learning about 
their diagnosis, study participants were motivated to mobilize their resources to ameliorate 
PID. Instrumental and emotional support from family and friends facilitated PID self-
management. The young women incorporated PID self-management into their lives as part of 
their daily routine, which may or may not have been consistent with the prescribed medical 
protocol. Some young women extended PID treatment beyond the recommended period; that 
is, they took longer than 14 days to finish the antibiotic medication and/or returned for 
follow-up care more than 72 hours after diagnosis. The implications of patient deviations 
from treatment recommendations on clinical outcomes are unclear.  
Strengths and Limitations 
The current study had several limitations that were considered. All collected data 
were self-reported by study participants, which introduced the potential for recall bias. Recall 
bias may have been unintentional due to poor or incomplete memory recall, or intentional 
due to perceived social desirability. However, the use of ACASI has been shown to decrease 
the underreporting of sensitive data, including data related to sexual/reproductive health 
(Ghanem, Hutton, Zenilman, Zimba, & Erbelding, 2005; Rogers et al., 2005). Further, study 
team members engaged in rapport-building to increase participants' comfort with sharing 
information during face-to-face quantitative and qualitative data collection. The relatively 
small sample size may not have had sufficient power to detect some meaningful differences 
as statistically significant. Study results were based on a sample of RCT participants from 
one urban academic health center and therefore may not be generalizable to other groups of 




time of TECH-N study enrollment, all participants received a full 14-day course of PID 
medications at no monetary cost to them, thereby eliminating financial and physical barriers 
to obtaining treatment (and subsequent medication adherence) that young women outside this 
study could encounter.  
 The major strength of this study was the use of a mixed methods design to enhance 
contextual understanding of PID self-management among young women who resided in a 
community with high STI rates (Maryland Department of Health, 2017). While previous 
studies concerning adherence to PID treatment recommendations have been limited to 
correlations with demographic characteristics such as age, the current study investigated 
relationships between PID treatment adherence and psychosocial factors such as situation-
specific coping and social support. In-depth interviews with young women diagnosed with 
and treated for PID elucidated the processes of PID self-care, providing insights that could 
not be gained from quantitative data.  
Contributions to Science 
In this study, quantitative and qualitative data were collected and analyzed to identify 
relationships between coping strategies, social support, and adherence to PID treatment 
recommendations. Psychosocial factors that promote or hinder PID self-management among 
young women were not examined in previous studies. The current study explored PID self-
management among a group at elevated risk for PID recurrence and reproductive 
complications—young women residing in an urban area with high STI prevalence—to reveal 
successes as well as opportunities to improve adherence to PID treatment recommendations. 
The current study also advanced the representation of adolescents in PID self-management 




women 18 years of age and older, this study explored the experiences of adolescents as 
young as 14 years old. 
Practice and Policy Implications 
PID during adolescence and young adulthood increases vulnerability to long-term 
adverse reproductive health outcomes and negative health-related quality of life. It is 
important for interdisciplinary health care providers to understand the roles of psychosocial 
factors, such as coping and social support, in PID self-management to develop and 
implement effective strategies to improve health outcomes among young women with PID. 
Qualitative results suggest that the PID diagnosis should be accompanied by an assessment 
of the patient’s appraisals of PID and her plans and resources for PID self-management. This 
would grant clinicians an opportunity to clarify and/or reinforce information and offer 
encouragement related to PID self-management. The low rate of 72-hour follow-up visit 
attendance among study participants and their subsequent interview responses indicate the 
need for improved patient education related to clinical follow-up visit attendance, which 
should include an explanation for returning for clinical evaluation within 72 hours of PID 
diagnosis and initiation of treatment. Clinicians should assist with access to follow-up care 
for young women who do not have a primary care provider or encounter barriers to making a 
follow-up appointment with their primary care provider. In the context of administrative 
policy, it is important for primary care providers to have appointment times available for 
short-notice scheduling of clinical follow-up visits. Some interview participants described 
attempting to schedule a 72-hour follow-up appointment with their primary care provider and 
being told that there were no available appointments during that period, and that they had to 




Study results indicated that feeling responsible for the well-being of others is 
associated with medication adherence and clinical appointment attendance. Therefore, 
connecting PID self-management to young women’s sense of responsibility for others may 
increase adherence to PID treatment recommendations. Study findings also revealed that 
participants understood the importance of completing an antibiotic treatment regimen, even if 
they missed a scheduled dose, thus indicating the positive influence of patient education and 
clinician encouragement on medication adherence. Nurses are positioned for vital roles in 
PID diagnosis counseling and personalized PID self-management support. PID diagnosis 
counseling should include an assessment of the young woman’s coping resources and 
diagnosis disclosure plans. Asking a young woman who she plans to tell about her PID 
diagnosis would reveal potential sources of emotional and/or instrumental support. Young 
women who are unable to identify trusted family members, friends, or other persons may 
need self-management support from nurses throughout the treatment period. Personalized 
PID self-management support could include outreach or extended communication in the form 
of periodic phone calls, text messages, or other electronic communication to check on the 
young women and provide encouragement. It would also be beneficial to have a system in 
place to receive and respond to contact initiated by the young women. Community health 
nursing could also be used to deliver personalized PID self-management support by meeting 
the women where they reside and bringing the clinical care and health promotion to them.  
Recommendations for Future Research 
The current study lays the groundwork for future research aimed at understanding the 
influences on PID treatment adherence among young women. Additional quantitative 




strategies, perceived social support, task-specific support such as medication reminders, and 
emotional support such as comfort are associated with PID self-management. Longitudinal 
studies that collect coping and social support data at multiple points during the treatment 
period would enhance understanding of their roles in PID self-management over time. 
Qualitative research to explore experiences with PID diagnosis and treatment in diverse 
populations and settings would provide a more comprehensive view of PID self-management 
among young women. Future study samples should reflect the racial/ethnic diversity of PID 
incidence and prevalence. Acknowledging that the lifetime self-reported history of PID 
diagnosis among non-Hispanic Black and non-Hispanic White sexually experienced women 
of reproductive age (18-44 years) in the United States with a previous STI diagnosis is nearly 
equal (10.0 % vs. 10.3%) (Kreisel, Torrone, Bernstein, Hong, & Gorwitz, 2017), it is 
important for health promotion research to include all groups affected by the disease. Future 
research should examine other factors in addition to coping and social support (e.g., self-
esteem) for more comprehensive analyses of the psychosocial influences on PID self-
management among young women, which may inform the development of effective care 
plans to subsequently improve sexual/reproductive health outcomes and quality of life across 
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These items (sentences) deal with ways you have been coping with the stress in your life 
since you found out you had pelvic inflammatory disease (PID). There are many ways to try 
to deal with problems. These items ask what you have been doing to cope with PID. 
Different people deal with things in different ways, but we are interested in how you have 
tried to deal with PID. Each item says something about a particular way of coping. We want 
to know how much you have been doing what the item says. Please do not answer based on 
whether it seems to be working or not—just whether or not you are doing it. Please use the 
response choices provided below. Try to rate each item separately from the others. Make 
your answers as true FOR YOU as you can. 
  
Response Choices 
1 = I haven't been doing this at all  
2 = I've been doing this a little bit  
3 = I've been doing this a medium amount  
4 = I've been doing this a lot 
 
Items 
1.  I have been turning to work or other activities to take my mind off things.  
2.  I have been concentrating my efforts on doing something about the situation I am in.  
3.  I have been saying to myself, "This isn't real."  
4.  I have been using alcohol or other drugs to make myself feel better.  
5.  I have been getting emotional support from others.  
6.  I have been giving up trying to deal with it.  
7.  I have been taking action to try to make the situation better.  
8.  I have been refusing to believe that it has happened.  
9.  I have been saying things to let my unpleasant feelings escape.  
10.  I have been getting help and advice from other people.  
11.  I have been using alcohol or other drugs to help me get through it.  
12.  I have been trying to see it in a different light, to make it seem more positive.  
13.  I have been criticizing myself.  
14.  I have been trying to come up with a strategy about what to do.  
15.  I have been getting comfort and understanding from someone.  
16.  I have been giving up the attempt to cope.  
17.  I have been looking for something good in what is happening.  
18.  I have been making jokes about it.  
19.  I have been doing something to think about it less, such as going to movies, watching 
TV, reading, daydreaming, sleeping, or shopping.  
20.  I have been accepting the reality of the fact that it has happened.  
21.  I have been expressing my negative feelings.  
22.  I have been trying to find comfort in my religion or spiritual beliefs.  
23.  I have been trying to get advice or help from other people about what to do.  
24.  I have been learning to live with it.  
25.  I have been thinking hard about what steps to take.  




27.  I have been praying or meditating.  
28.  I have been making fun of the situation. 
 
Scales (computed with no reversals of coding) 
Self-distraction, items 1 and 19  
Active coping, items 2 and 7  
Denial, items 3 and 8  
Substance use, items 4 and 11  
Use of emotional support, items 5 and 15  
Use of instrumental support, items 10 and 23  
Behavioral disengagement, items 6 and 16  
Venting, items 9 and 21  
Positive reframing, items 12 and 17  
Planning, items 14 and 25  
Humor, items 18 and 28  
Acceptance, items 20 and 24  
Religion, items 22 and 27  
Self-blame, items 13 and 26  
 





Qualitative Interview Guide 
 
1. Tell me about your experience with PID. 
a. Finding out, severity, previous knowledge (STI-PID connection), HCP info & interactions, told 
anyone 
i. When the MD/RN told you that you had PID, what was the first thought that came to 
mind? How bad did you think it was? 
b. Some women say they feel sad, angry, dirty, or other ways when they find out that they have 
PID, other women say they don’t feel anything at all. How did you feel when you found out you 
had PID? 
c. [If difficulty expressing] How would you compare PID to other challenges that you have had? 
2. What did you do after you found out you had PID?  
a. Next move after you left the ED/clinic/MD office 
b. There are many ways to try to deal with problems, and different people deal with problems in 
different ways, like trying to figure out a way to fix the problem, trying not to think about it, 
denying that anything really happened, getting support from other people, or giving up trying to 
deal with it. How did you try to deal with having PID? 
c. What/Who helped and how 
3. Tell me about a typical day for you while you were being treated for PID.  
a. Work/school, Rx routine and challenges, follow-up visit, recall non-typical day 
b. At what point in time did you feel like your PID was over (no longer a problem)? Do you feel 
like PID is still an issue for you? Are you still having any problems related to PID? 
4. I’d like to ask you about your sexual activity after you found out you had PID. Can you 
tell me about it? 
a. Partner(s) and relationship(s), notification & treatment, sexual activity change, condoms 
5. What would you say was the hardest part about taking care of your PID?  
6. What was the easiest part about taking care of your PID?  
7. Knowing what you know now about having PID, if you could go back to the day you 
found out you had PID, what advice would you give to yourself?  
8. Years ago, women with PID had to stay in the hospital until their pain got better. How 
would it have affected you if the doctor had decided that you needed to stay in the 
hospital? 
9. Before we end the interview, is there anything else you would like to say, or anything 
else you would like for me to know about your experience with PID?  





Administer verbally to participants 
 
Demographic and Social Information 
1. How did you find out about this study?  
a. Phone call 
b. E-mail  
c. Flyer 
d. TECH-N outreach worker (Jackie) 
 
2. Date of birth 
 
3. How old are you? 
 
4. With which race(s)/ethnicity do you identify? Select all that apply. 
a. Black/African American 
b. White/European American 
c. Native American/Pacific Islander 
d. Asian 
e. Hispanic 
f. Other _____________ 
 
5. If more than one race/ethnicity, with which do you identify the most? 
a. Black/African American 
b. White/European American 
c. Native American/Pacific Islander 
d. Asian 
e. Hispanic 
f. Other ____________ 
 
6. What is the highest level of education you have completed? 
 
a. Are you currently in school? 
i. Which grade/level/classification?  
ii. Where? 
 
7. What is your mother’s highest level of education? 
 
8. Do you currently have a job? 
a. Full-time or part-time? 
 
9. Did you have a job around the time you had PID? 
a. Full-time or part-time?  
 
10. Do you currently have health insurance? 





11. Did you have health insurance when you had PID? 
a. Name of health insurance plan  
 
12. With whom do you currently live? 
 
13. With whom were you living when you had PID?  
 
14. If you needed help with something important, whom would you count on? 
 
15. Were you in a relationship around the time you had PID? 
 
Health Information 
1. Date of PID diagnosis 
 
2. Age at PID diagnosis 
 
3. Do you have a primary care provider (doctor or clinic)? 
a. Name? 
 
4. At which health care facility were you diagnosed with PID?  
 
5. Did you take all of the antibiotic pills that were given to you for PID? 
a. If not, around how many pills were left over? 
 
6. Did you take any medicine for pain relief while you had PID? 
a. What pain medicine did you take? 
i. Tylenol/acetaminophen 
ii. Advil/Motrin/ibuprofen 
iii. Aleve/naproxen sodium 
iv. Other 
 
7. Did you go back to see a doctor or other health care provider within 3 days after you 
were diagnosed with PID?  
a. If yes, where did you go for your follow-up visit?  
 
b. If no, did you see a doctor at any point while you were being treated for PID? 
 
8. How many times have you had PID? 
 
9. Have you ever had any of the following sexually transmitted infections? How many 
times? Before or after PID? (Document in table below) 
a. No prior STIs 
b. Chlamydia 
c. Gonorrhea 




e. Mycoplasma genitalium 
f. Genital herpes 





STI Before PID After PID 
Chlamydia   
Gonorrhea   
Trichomonas vaginalis   
Mycoplasma genitalium   
Genital Herpes   
Genital warts/HPV   
HIV   
Syphilis   
Other _______________   
 
10. How old were you the first time you had sex? 
 


















h. Tubal ligation 




14. Which form(s) of birth control were you using around the time you were diagnosed 
with PID? 











i. Tubal ligation 




15. How many times have you been pregnant? (Document in table below) 
a. Was the pregnancy before or after PID? 
b. What were the outcomes of those pregnancies? 
 
Pregnancy Before PID After PID Outcome 
1    
2    
3    
4    
5    
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